Genpact Limited (G) 10-Q 12 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 08, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-33626
Entity Registrant Name	GENPACT LIMITED
Entity Incorporation, State or Country Code	D0
Entity Tax Identification Number	98-0533350
Entity Address, Address Line One	Canon's Court
Entity Address, Address Line Two	22 Victoria Street
Entity Address, City or Town	Hamilton
Entity Address, Postal Zip Code	HM 12
Entity Address, Country	BM
City Area Code	441
Local Phone Number	298-3300
Title of 12(b) Security	Common shares, par value $0.01 per share
Trading Symbol	G
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		176,361,269
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001398659
Current Fiscal Year End Date	--12-31

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 1,022,647	$ 583,670
Accounts receivable, net of allowance for credit losses of $18,278 and $14,833 as of December 31, 2023 and September 30, 2024, respectively	1,214,098	1,116,273
Prepaid expenses and other current assets	164,064	191,566
Total current assets	2,400,809	1,891,509
Property, plant and equipment, net	207,592	189,803
Operating lease right-of-use assets	185,666	186,167
Deferred tax assets	288,773	298,921
Intangible assets, net	33,337	53,028
Goodwill	1,683,053	1,683,782
Contract cost assets	200,440	202,543
Other assets, net of allowance for credit losses of $4,096 and $6,440 as of December 31, 2023 and September 30, 2024, respectively	325,990	299,960
Total assets	5,325,660	4,805,713
Current liabilities
Short-term borrowings	0	10,000
Current portion of long-term debt	426,069	432,242
Accounts payable	18,513	27,739
Income taxes payable	52,793	38,458
Accrued expenses and other current liabilities	747,489	759,180
Operating leases liability	49,865	50,313
Total current liabilities	1,294,729	1,317,932
Long-term debt, less current portion	1,201,439	824,720
Operating leases liability	162,004	168,015
Deferred tax liabilities	11,577	11,706
Other liabilities	261,218	234,948
Total liabilities	2,930,967	2,557,321
Shareholders' equity
Preferred shares, $0.01 par value, 250,000,000 authorized, none issued	0	0
Common shares, $0.01 par value, 500,000,000 authorized, 179,494,132 and 176,347,167 issued and outstanding as of December 31, 2023 and September 30, 2024, respectively	1,758	1,789
Additional paid-in capital	1,922,042	1,883,944
Retained earnings	1,207,387	1,085,209
Accumulated other comprehensive income (loss)	(736,494)	(722,550)
Total equity	2,394,693	2,248,392
Commitments and contingencies
Total liabilities and equity	$ 5,325,660	$ 4,805,713

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 14,833	$ 18,278
Allowance for credit losses, other assets	$ 6,440	$ 4,096
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	250,000,000	250,000,000
Preferred shares, issued (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	500,000,000	500,000,000
Common shares, issued (in shares)	176,347,167	179,494,132
Common shares, outstanding (in shares)	176,347,167	179,494,132

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net revenues	$ 1,210,949	$ 1,135,792	$ 3,518,398	$ 3,330,635
Cost of revenue	779,511	732,962	2,274,104	2,167,524
Gross profit	431,438	402,830	1,244,294	1,163,111
Operating expenses:
Selling, general and administrative expenses	243,315	229,731	717,988	675,642
Amortization of acquired intangible assets	6,495	7,497	19,980	24,009
Other operating (income) expense, net	(22)	(91)	(5,561)	(4,665)
Income from operations	181,650	165,693	511,887	468,125
Foreign exchange gains, net	1,133	2,975	4,424	3,698
Interest income (expense), net	(12,387)	(13,255)	(36,167)	(35,020)
Other income (expense), net	5,091	(508)	14,128	6,947
Income before income tax expense	175,487	154,905	494,272	443,750
Income tax expense	42,669	37,312	122,517	103,804
Net income	$ 132,818	$ 117,593	$ 371,755	$ 339,946
Earnings per common share
Earnings per common share, basic (in usd per share)	$ 0.75	$ 0.65	$ 2.07	$ 1.86
Earnings per common share, diluted (in usd per share)	$ 0.74	$ 0.64	$ 2.06	$ 1.83
Weighted average number of common shares used in computing earnings per common share
Weighted average number of common shares used in computing basic earnings per common share (in shares)	177,595,400	181,399,897	179,221,213	182,808,518
Weighted average number of common shares used in computing diluted earnings per common share (in shares)	179,714,223	183,801,791	180,854,682	185,737,729

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 132,818	$ 117,593	$ 371,755	$ 339,946
Other comprehensive income:
Currency translation adjustments	22,765	(30,391)	(1,695)	(21,283)
Gain (loss) on cash flow hedging derivatives, net of taxes (Note 5)	(18,583)	(10,677)	(11,810)	10,963
Retirement benefits (expense), net of taxes	(185)	201	(439)	1,246
Other comprehensive income (loss)	3,997	(40,867)	(13,944)	(9,074)
Comprehensive income	$ 136,815	$ 76,726	$ 357,811	$ 330,872

Consolidated Statements of Equi

Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Common shares	Additional  Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		182,924,416
Beginning balance, value at Dec. 31, 2022	$ 1,826,158	$ 1,823	$ 1,777,453	$ 780,007	$ (733,125)
Issuance of common shares on exercise of options (in shares)		1,287,280
Issuance of common shares on exercise of options (Note 15)	25,437	$ 13	25,424
Issuance of common shares under the employee stock purchase plan (in shares)		255,123
Issuance of common shares under the employee stock purchase plan (Note 15)	9,201	$ 3	9,198
Net settlement on vesting of restricted share unit (in shares)		361,389
Net settlement on vesting of restricted share units (Note 15)	(8,644)	$ 4	(8,648)
Net settlement on vesting of performance units (in shares)		412,275
Net settlement on vesting of performance units (Note 15)	$ (11,043)	$ 4	(11,047)
Stock repurchased and retired (in shares)	(3,828,084)	(3,828,084)
Stock repurchased and retired (Note 16)	$ (150,471)	$ (38)		(150,433)
Expenses related to stock repurchased, including taxes (Note 16)	(677)			(677)
Stock-based compensation expense (Note 15)	63,850		63,850
Comprehensive income (loss):
Net income (loss)	339,946			339,946
Other comprehensive income (loss)	(9,074)				(9,074)
Dividends	(75,230)			(75,230)
End balance (in shares) at Sep. 30, 2023		181,412,399
End balance, value at Sep. 30, 2023	2,009,453	$ 1,809	1,856,230	893,613	(742,199)
Beginning balance (in shares) at Jun. 30, 2023		181,318,104
Beginning balance, value at Jun. 30, 2023	1,932,864	$ 1,807	1,831,425	800,964	(701,332)
Issuance of common shares under the employee stock purchase plan (in shares)		80,650
Issuance of common shares under the employee stock purchase plan (Note 15)	2,710	$ 1	2,709
Net settlement on vesting of restricted share unit (in shares)		13,645
Net settlement on vesting of restricted share units (Note 15)	(217)	$ 1	(218)
Net settlement on vesting of performance units (Note 15)	0
Stock repurchased and retired (Note 16)	0
Expenses related to stock repurchased, including taxes (Note 16)	0
Stock-based compensation expense (Note 15)	22,314		22,314
Comprehensive income (loss):
Net income (loss)	117,593			117,593
Other comprehensive income (loss)	(40,867)				(40,867)
Dividends	(24,944)			(24,944)
End balance (in shares) at Sep. 30, 2023		181,412,399
End balance, value at Sep. 30, 2023	$ 2,009,453	$ 1,809	1,856,230	893,613	(742,199)
Beginning balance (in shares) at Dec. 31, 2023	179,494,132	179,494,132
Beginning balance, value at Dec. 31, 2023	$ 2,248,392	$ 1,789	1,883,944	1,085,209	(722,550)
Issuance of common shares on exercise of options (in shares)	135,051	135,051
Issuance of common shares on exercise of options (Note 15)	$ 3,931	$ 1	3,930
Issuance of common shares under the employee stock purchase plan (in shares)		261,281
Issuance of common shares under the employee stock purchase plan (Note 15)	8,239	$ 3	8,236
Net settlement on vesting of restricted share unit (in shares)		307,298
Net settlement on vesting of restricted share units (Note 15)	(4,428)	$ 3	(4,431)
Net settlement on vesting of performance units (in shares)		869,713
Net settlement on vesting of performance units (Note 15)	$ (16,904)	$ 9	(16,913)
Stock repurchased and retired (in shares)	(4,720,308)	(4,720,308)
Stock repurchased and retired (Note 16)	$ (167,562)	$ (47)		(167,515)
Expenses related to stock repurchased, including taxes (Note 16)	(294)			(294)
Stock-based compensation expense (Note 15)	47,276		47,276
Comprehensive income (loss):
Net income (loss)	371,755			371,755
Other comprehensive income (loss)	(13,944)				(13,944)
Dividends	$ (81,768)			(81,768)
End balance (in shares) at Sep. 30, 2024	176,347,167	176,347,167
End balance, value at Sep. 30, 2024	$ 2,394,693	$ 1,758	1,922,042	1,207,387	(736,494)
Beginning balance (in shares) at Jun. 30, 2024		178,177,581
Beginning balance, value at Jun. 30, 2024	2,337,759	$ 1,776	1,900,015	1,176,459	(740,491)
Issuance of common shares under the employee stock purchase plan (in shares)		69,393
Issuance of common shares under the employee stock purchase plan (Note 15)	2,450	$ 1	2,449
Net settlement on vesting of restricted share unit (in shares)		35,513
Net settlement on vesting of restricted share units (Note 15)	(148)		(148)
Stock repurchased and retired (in shares)		(1,935,320)
Stock repurchased and retired (Note 16)	(74,932)	$ (19)		(74,913)
Expenses related to stock repurchased, including taxes (Note 16)	(38)			(38)
Stock-based compensation expense (Note 15)	19,726		19,726
Comprehensive income (loss):
Net income (loss)	132,818			132,818
Other comprehensive income (loss)	3,997				3,997
Dividends	$ (26,939)			(26,939)
End balance (in shares) at Sep. 30, 2024	176,347,167	176,347,167
End balance, value at Sep. 30, 2024	$ 2,394,693	$ 1,758	$ 1,922,042	$ 1,207,387	$ (736,494)

Consolidated Statements of Eq_2

Consolidated Statements of Equity (Parenthetical) - $ / shares	3 Months Ended					9 Months Ended		12 Months Ended
	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends per common share (in usd per share)	$ 0.1525	$ 0.1525	$ 0.1375	$ 0.1375	$ 0.125	$ 0.4575	$ 0.413	$ 0.55	$ 0.50

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net income	$ 371,755	$ 339,946
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	51,830	54,410
Amortization of debt issuance costs	1,749	1,473
Amortization of acquired intangible assets	19,980	24,009
Loss on the sale of business classified as held for sale (refer to Note 7)	0	802
Allowance for credit losses (refer to Note 3)	12,395	5,081
Unrealized gain (loss) on revaluation of foreign currency assets/liabilities	(7,909)	1,283
Stock-based compensation expense	47,276	63,850
Deferred tax (benefit) expense	14,509	(7,092)
Others, net	386	1,512
Change in operating assets and liabilities:
Increase in accounts receivable	(95,790)	(73,400)
Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets	(5,752)	(110,227)
Decrease in accounts payable	(8,021)	(9,196)
Decrease in accrued expenses, other current liabilities, operating leases liabilities and other liabilities	(5,056)	(80,694)
Increase in income taxes payable	14,825	87,149
Net cash provided by operating activities	412,177	298,906
Investing activities
Purchase of property, plant and equipment	(63,049)	(37,330)
Payment for internally generated intangible assets (including intangibles under development)	(1,787)	(2,569)
Proceeds from sale of property, plant and equipment	128	21
Payment for business acquisitions, net of cash acquired	0	(682)
Payment for divestiture of business	0	(19,510)
Net cash used for investing activities	(64,708)	(60,070)
Financing activities
Repayment of finance lease obligations	(8,238)	(9,168)
Payment of debt issuance and refinancing costs	(4,123)	0
Proceeds of long-term debt	400,000	0
Repayment of long-term debt	(26,500)	(19,875)
Proceeds from short-term borrowings	50,000	148,000
Repayment of short-term borrowings	(60,000)	(244,000)
Proceeds from issuance of common shares under stock-based compensation plans	12,170	34,638
Payment for net settlement of stock-based awards	(21,307)	(19,687)
Payment of earn-out consideration	0	(2,399)
Dividend paid	(81,768)	(75,230)
Payment for stock repurchased and retired (including expenses related to stock repurchased)	(167,656)	(150,548)
Net cash (used for) provided by financing activities	92,578	(338,269)
Net (decrease) increase in cash and cash equivalents	440,047	(99,433)
Effect of exchange rate changes	(1,070)	(6,328)
Cash and cash equivalents at the beginning of the period	583,670	646,765
Cash and cash equivalents at the end of the period	1,022,647	541,004
Supplementary information
Cash paid during the period for interest	39,180	31,551
Cash paid during the period for income taxes, net of refund	$ 77,983	$ 123,395

Organization

Organization	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Organization	OrganizationThe Company is a global professional services firm that drives digitally-led innovation and runs digitally-enabled intelligent operations for its clients, guided by its experience running thousands of processes for hundreds of Fortune Global 500 clients. The Company has over 138,500 employees serving clients in key industry verticals from more than 35 countries.

Summary of significant accounti

Summary of significant accounting policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Summary of significant accounting policies	Summary of significant accounting policies (a) Basis of preparation and principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for reporting on Form 10-Q. Accordingly, they do not include certain information and note disclosures required by generally accepted accounting principles for annual financial reporting and should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accompanying consolidated financial statements reflect all adjustments that management considers necessary for a fair presentation of the results of operations for these periods. The accompanying financial statements have been prepared on a consolidated basis and reflect the financial statements of Genpact Limited, a Bermuda company, and all of its subsidiaries that are more than 50% owned and controlled. When the Company does not have a controlling interest in an entity but exerts significant influence over the entity, the Company applies the equity method of accounting. All intercompany transactions and balances are eliminated in consolidation. (b) Use of estimates The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements. Significant items subject to such estimates and assumptions include the useful lives of property, plant and equipment, intangible assets and goodwill, revenue recognition, allowance for credit losses, valuation allowances for deferred tax assets, valuation of derivative financial instruments, measurement of lease liabilities and right-of-use (“ROU”) assets, measurements of stock-based compensation, assets and obligations related to employee benefits, nature and timing of the satisfaction of performance obligations, standalone selling price of performance obligations, variable consideration, other obligations for revenue recognition, income tax uncertainties and other contingencies. Management believes that the estimates used in the preparation of the consolidated financial statements are reasonable. Although these estimates and assumptions are based upon management’s best knowledge of current events and actions, actual results could differ from these estimates. Any changes in estimates are adjusted prospectively in the Company’s consolidated financial statements. (c) Business combinations, goodwill and other intangible assets The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and any non-controlling interest in the acquired business, measured at their acquisition date fair values. Contingent consideration is included within the acquisition cost and is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value as of each reporting date until the contingency is resolved. Changes in fair value are recognized in earnings. All assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition-related costs are expensed as incurred under selling, general and administrative expenses. 2. Summary of significant accounting policies (Continued) Goodwill represents the cost of acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased. Goodwill is not amortized but is tested for impairment at least on an annual basis on December 31, based on a number of factors, including operating results, business plans and future cash flows. The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs a quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of a reporting unit exceeds the fair value of such goodwill, an impairment loss is recognized in an amount equal to the excess. In addition, the Company performs a qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would mor e likely than not reduce the fair value of a reporting unit below its carrying amount. See Note 9 for information and related disclosures. Intangible assets acquired individually or with a group of other assets or in a business combination and developed internally are carried at cost less accumulated amortization and accumulated impairment loss based on their estimated useful lives as follows: Customer-related intangible assets 1 - 8 years Marketing-related intangible assets 1 - 8 years Technology-related intangible assets 2 - 10 years Intangible assets are amortized over their estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized. In business combinations where the fair value of identifiable tangible and intangible net assets purchased exceeds the cost of the acquired business, the Company recognizes the resulting gain under “Other operating (income) expense, net” in the consolidated statements of income. The Company also capitalizes certain software and technology-related development costs incurred in connection with developing or obtaining software or technology for sale/lease to customers when the initial design phase is completed and commercial and technological feasibility has been established. Any development cost incurred before technological feasibility is established is expensed as incurred as research and development costs. Technological feasibility is established upon completion of a detailed design program or, in its absence, completion of a working model. Capitalized software and technology costs include only (i) external direct costs of materials and services utilized in developing or obtaining software and technology and (ii) compensation and related benefits for employees who are directly associated with the project. Costs incurred in connection with developing or obtaining software or technology for sale/lease to customers which are under development and not put to use are disclosed under “intangible assets under development.” Advances paid towards the acquisition of intangible assets outstanding as of each balance sheet date are disclosed under “intangible assets under development.” Capitalized software and technology costs are included in intangible assets under technology-related intangible assets on the Company’s balance sheet and are amortized on a straight-line basis when placed into service over the estimated useful lives of the software and technology. The Company evaluates the remaining useful life of intangible assets that are being amortized at each reporting period wherever events and circumstances warrant a revision to the remaining period of amortization, and the remaining carrying amount of the intangible asset is amortized prospectively over that revised remaining useful life. 2. Summary of significant accounting policies (Continued) (d) Financial instruments and concentration of credit risk Financial instruments that potentially subject the Company to concentration of credit risk are reflected principally in cash and cash equivalents, derivative financial instruments and accounts receivable. The Company places its cash and cash equivalents and derivative financial instruments with corporations and banks with high investment grade ratings, limits the amount of credit exposure with any one corporation or bank and conducts ongoing evaluations of the creditworthiness of the corporations and banks with which it does business. To reduce its credit risk on accounts receivable, the Company conducts ongoing credit evaluations of its customers. (e) Accounts receivable Accounts receivable are recorded at the invoiced or to be invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company maintains an allowance for current expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses which are adjusted to current market conditions and a reasonable and supportable forecast. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company uses revolving accounts receivable-based facilities in the normal course of business as part of managing its cash flows. The Company accounts for receivables sold under these facilities as a sale of financial assets pursuant to ASC 860 “Transfers and Servicing” and de-recognizes these receivables, as well as the related allowances, from its balance sheets. Generally, the fair value of accounts receivable sold approximates their book value due to their short-term nature, and any gains or losses on the sale of these receivables are recorded at the time of transfer and included under "interest income (expense), net" in the Company’s consolidated statements of income. (f) Revenue Recognition The Company derives its revenue primarily from business process management services, including analytics, consulting and related digital solutions and information technology services, which are provided primarily on a time-and-material, transaction or fixed-price basis. The Company recognizes revenue upon the transfer of control of promised services to its customers in an amount that reflects the consideration the Company expects to receive in exchange for those services. Revenues from services rendered under time-and-materials and transaction-based contracts are recognized as the services are provided. The Company’s fixed-price contracts include contracts for customization of applications, maintenance and support services. Revenues from these contracts are recognized ratably over the term of the agreement. The Company accrues for revenue and unbilled receivables for services rendered between the last billing date and the balance sheet date. The Company’s contracts with its customers also include incentive payments received for discrete benefits delivered or promised to be delivered to the customer or service level agreements that could result in credits or refunds to the customer. Revenues relating to such arrangements are accounted for as variable consideration when the amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur. The Company records deferred revenue attributable to certain process transition activities where such activities do not represent separate performance obligations. Revenues relating to such transition activities are classified under contract liabilities and subsequently recognized ratably over the period in which the related services are performed. Costs relating to such transition activities are fulfillment costs which are directly related to the contract and result in the enhancement of resources. Such costs are expected to be recoverable under the contract and are therefore classified as contract cost assets and recognized ratably over the estimated expected period of benefit under cost of revenue. 2. Summary of significant accounting policies (Continued) Revenues are reported net of value-added tax, business tax and applicable discounts and allowances. Reimbursements of out-of-pocket expenses received from customers have been included as part of revenues. Revenue for performance obligations that are satisfied over time is recognized in accordance with the methods prescribed for measuring progress. The input (cost expended) method has been used to measure progress towards completion as there is a direct relationship between input and the satisfaction of a performance obligation. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates. The Company enters into multiple-element revenue arrangements in which a customer may purchase a combination of products or services. The Company determines whether each product or service promised to a customer is capable of being distinct, and is distinct in the context of the contract. If not, the promised products or services are combined and accounted for as a single performance obligation. In the event of a multiple-element revenue arrangement, the Company allocates the arrangement consideration to separately identifiable performance obligations based on their relative stand-alone selling prices. Certain contracts may include offerings such as sale of licenses, which may be perpetual or subscription-based. Revenue from distinct, non-cancellable, subscription-based licenses is recognized at the point in time it is transferred to the customer. Revenue from any associated maintenance or ongoing support services is recognized ratably over the term of the contract. For a combined software license/services performance obligation, revenue is recognized over the period that the services are performed. All incremental and direct costs incurred for acquiring contracts, such as certain sales commissions, are classified as contract cost assets. Such costs are amortized over the expected period of benefit and recorded under selling, general and administrative expenses. Other upfront fees paid to customers are classified as contract assets. Such fees are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and deducted from revenue. Timing of revenue recognition may differ from the timing of invoicing. If a payment is received in respect of services prior to the delivery of services, the payment is recognized as an advance from the customer and classified as a contract liability. Contract assets and contract liabilities relating to the same customer contract are offset against each other and presented on a net basis in the consolidated financial statements. 2. Summary of significant accounting policies (Continued) (g) Leases At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on whether: (1) the contract involves the use of a distinct identified asset, (2) the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term of the contract, and (3) the Company has the right to direct the use of the asset. At the inception of a lease, the consideration in the contract is allocated to each lease component based on its relative standalone price to determine the lease payments. Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of the above criteria. For all leases at the lease commencement date, a ROU asset and a lease liability are recognized. The lease liability represents the present value of the lease payments under the lease. Lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using the discount rate for the lease at the lease commencement. The lease liabilities are subsequently measured on an amortized cost basis. The lease liability is adjusted to reflect interest on the liability and the lease payments made during the period. Interest on the lease liability is determined as the amount that results in a constant periodic discount rate on the remaining balance of the liability. The ROU asset represents the right to use the leased asset for the lease term. The ROU asset for each lease initially includes the amount of the initial measurement of the lease liability adjusted for any lease payments made to the lessor at or before the commencement date, accrued lease liabilities and any lease incentives received or any initial direct costs incurred by the Company. The ROU asset of finance leases is subsequently measured at cost, less accumulated amortization and any accumulated impairment losses. The ROU asset of operating leases is subsequently measured from the carrying amount of the lease liability at the end of each reporting period, and is equal to the carrying amount of lease liabilities adjusted for (1) unamortized initial direct costs, (2) prepaid/(accrued) lease payments and (3) the unamortized balance of lease incentives received. The carrying value of ROU assets is reviewed for impairment, similar to long-lived assets, whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. The Company has elected to not separate lease and non-lease components for all of its leases and to use the recognition exemptions for lease contracts that, at commencement date, have a lease term of 12 months or less and do not contain a purchase option (“short-term leases”). Significant judgements The Company determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised. Under certain of its leases, the Company has a renewal and termination option to lease assets for additional terms between one 2. Summary of significant accounting policies (Continued) The Company has applied an incremental borrowing rate for the purpose of computing lease liabilities based on the remaining lease term and the rates prevailing in the jurisdictions where leases were executed. (h) Cost of revenue Cost of revenue primarily consists of salaries and benefits (including stock-based compensation), recruitment, training and related costs of employees who are directly responsible for the performance of services for customers, their supervisors and certain support personnel who may be dedicated to a particular client or a set of processes. It also includes operational expenses, such as facilities maintenance expenses, travel and living expenses, rent, IT expenses, contract resources with specialized skills who are directly responsible for the performance of services for clients, and other billable costs related to the Company’s clients. It also includes depreciation of property, plant and equipment, and amortization of intangible and ROU assets which are directly related to providing services that generate revenue. (i) Selling, general and administrative expenses Selling, general and administrative (“SG&A”) expenses consist of expenses relating to salaries and benefits (including stock-based compensation) as well as costs related to recruitment, training and retention of senior management and other support personnel in enabling functions such as human resources, finance, legal, marketing, sales and sales support, and other support personnel. The operational costs component of SG&A expenses also includes travel and living costs for such personnel. SG&A expenses also include acquisition-related costs, legal and professional fees (which represent the costs of third party legal, tax, accounting and other advisors), investment in research and development, digital technology, advanced automation and robotics, and an allowance for credit losses. It also includes depreciation of property, plant and equipment, and amortization of intangibles and ROU assets other than those included in cost of revenue. (j) Credit losses An allowance for credit losses is recognized for all debt instruments other than those held at fair value through profit or loss. The Company pools its accounts receivable (other than deferred billings) based on similar risk characteristics in estimating expected credit losses. Credit losses for accounts receivable are based on the roll-rate method, and the Company recognizes a loss allowance based on lifetime expected credit losses at each reporting date. The Company has established a provision matrix based on historical credit loss experience, adjusted for forward-looking factors and the economic environment. The Company believes the most relevant forward-looking factors are economic environment, gross domestic product, inflation rates and unemployment rates for each of the countries in which the Company or its customers operate, and accordingly the Company adjusts historical loss rates based on expected changes in these factors. At every reporting date, observed historical default rates are updated to reflect changes in the Company’s forward-looking estimates. Credit losses for other financial assets and deferred billings are based on the discounted cash flow (“DCF”) method. Under the DCF method, the allowance for credit losses reflects the difference between the contractual cash flows due in accordance with the contract and the present value of the cash flows expected to be collected. The expected cash flows are discounted at the effective interest rate of the financial asset. Such allowances are based on the credit losses expected to arise over the life of the asset which includes consideration of prepayments based on the Company’s expectation as of the balance sheet date. A financial asset is written off when it is deemed uncollectible and there is no reasonable expectation of recovering the contractual cash flows. Expected recoveries of amounts previously written off, not to exceed the aggregate amounts previously written off, are included in determining the allowance at each reporting period. Credit losses are presented as a credit loss expense within “Selling, general and administrative expenses.” Subsequent recoveries of amounts previously written off are credited against the same line item. 2. Summary of significant accounting policies (Continued) (k) Impairment of long-lived assets Long-lived assets, including certain intangible assets, to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Such assets are required to be tested for impairment if the carrying amount of the assets is higher than the future undiscounted net cash flows expected to be generated by the assets. The impairment amount to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. The Company determines fair value by using a discounted cash flow approach. (l) Assets held for sale A long-lived asset (or a disposal group for a long-lived asset comprising a group of assets and related liabilities) is classified as held for sale if it is highly probable that the asset will be recovered through sale rather than continuing use. The Company records assets held for sale at the lower of its carrying value or fair value less costs to sell. The following criteria are used to determine if a business is held for sale: (i) management, having the authority to approve a sale, commits to a plan to sell; (ii) the business is available for immediate sale in its present condition; (iii) an active program to locate a buyer and a plan to sell the business have been initiated; (iv) the sale of the business is probable within one year; (v) the business is being actively marketed for sale at a reasonable price relative to its fair value; and (vi) it is unlikely that the plan to sell will be withdrawn or that significant changes to the plan will be made. In determining the fair value of the assets less costs to sell, the Company considers factors including current sales prices for comparable assets, discounted cash flow projections, third party valuation and any indicative offers. The Company’s assumptions about fair value require significant judgment because the current market is highly sensitive to changes in economic conditions. The Company estimates the fair values of assets held for sale based on current market conditions and assumptions made by management, which may differ from actual results and may result in impairments if market conditions deteriorate. Any impairment loss on the initial classification and subsequent measurement is recognized as an expense. Any subsequent increase in fair value less costs to sell (not exceeding the accumulated impairment loss that has been previously recognized) is recognized in the income statement. When assets are classified as held for sale, the Company does not record any depreciation and amortization for the respective property, plant and equipment and intangibles. (m) Recently issued accounting pronouncements The authoritative bodies release standards and guidance which are assessed by management for impact on the Company’s consolidated financial statements. The following recently released accounting standard has been adopted by the Company: In March 2023, the FASB issued ASU No. 2023-01, “Leases (Topic 842).” This ASU requires a lessee in a common-control lease arrangement to amortize leasehold improvements that it owns over the improvements’ useful life to the common control group, regardless of the lease term, if the lessee continues to control the use of the underlying asset through a lease. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted this ASU beginning January 1, 2024. The adoption of this ASU did not have a material impact on the Company's consolidated results of operations, cash flows, financial position or disclosures. 2. Summary of significant accounting policies (Continued) The following recently released accounting standards have not yet been adopted by the Company: In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280)." This ASU improves reportable segment disclosure requirements by enhancing disclosures about significant segment expenses. It requires public entities to disclose significant segment expenses, other segment items, and additional measures of segment profit or loss, providing more comprehensive information for investors and stakeholders. The amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its disclosures. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740)." This ASU enhances income tax disclosures by requiring public business entities on an annual basis (1) to disclose specific categories in the rate reconciliation, and (2) to provide additional information for reconciling items that meet a quantitative threshold, i.e., if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate. It also requires entities to disclose the income taxes paid (net of refunds received), broken out between federal (national), state/local and foreign, as well as the amounts paid to an individual jurisdiction when 5% or more of the total income taxes were paid to such jurisdiction. The amendments in this ASU are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its disclosures.

Accounts receivable, net of all

Accounts receivable, net of allowance for credit losses	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Accounts receivable, net of allowance for credit losses	Accounts receivable, net of allowance for credit losses The following table provides details of the Company’s allowance for credit losses on accounts receivable: Year ended December 31, 2023 Nine months ended September 30, 2024 Opening balance as of January 1 $ 20,442 $ 18,278 Additions (net), charged to income statement 3,081 7,051 Deductions/effect of exchange rate fluctuations (5,245) (10,496) Closing balance $ 18,278 $ 14,833 Accounts receivable were $1,134,551 and $1,228,931, and allowances for credit losses were $18,278 and $14,833, resulting in net accounts receivable balances of $1,116,273 and $1,214,098 as of December 31, 2023 and September 30, 2024, respectively. In addition, deferred billings were $90,094 and $112,793 and allowances for credit losses on deferred billings were $4,096 and $6,440, resulting in net deferred billings balances of $85,998 and $106,353 as of December 31, 2023 and September 30, 2024, respectively. During the three months ended September 30, 2023 and 2024, the Company recorded a charge of $267 and $928, respectively, and for the nine months ended September 30, 2023 and 2024, a charge of $414 and $5,344, respectively, to the income statement on account of credit losses on deferred billings. Deferred billings, net of related allowances for credit losses, are included under “Other assets” in the Company ’ s consolidated balance sheet as of December 31, 2023 and September 30, 2024. 3. Accounts receivable, net of allowance for credit losses (Continued) The Company has a revolving accounts receivable-based facility of $75,000 and $60,000 as of December 31, 2023 and September 30, 2024, respectively, permitting it to sell accounts receivable to banks on a non-recourse basis in the ordinary course of business. The aggregate maximum capacity utilized by the Company at any time during the year ended December 31, 2023 and the nine months ended September 30, 2024 was $51,367 and $55,870, respectively. The principal amount outstanding against this facility as of December 31, 2023 and September 30, 2024 was $51,344 and $53,069, respectively. The cost of factoring such accounts receivable during the three and nine months ended September 30, 2023 and 2024 was $454 and $589, respectively, and $1,368 and $2,015, respectively. Gains or losses on the sales are recorded at the time of transfer of the accounts receivable and are included under "interest income (expense), net" in the Company ’ s consolidated statements of income. The Company also has arrangements with financial institutions that manage the accounts payable program for certain of the Company's large clients. The Company sells certain accounts receivable pertaining to such clients to these financial institutions on a non-recourse basis. There is no cap on the value of accounts receivable that can be sold under these arrangements. The Company used these arrangements to sell accounts receivable amounting to $324,401 during the year ended December 31, 2023, and $191,295 during the nine months ended September 30, 2024, which also represents the maximum capacity utilized under these arrangements in each such period. The cost of factoring such accounts receivable during the three and nine months ended September 30, 2023 and 2024 was $2,011 and $1,395, respectively, and $5,981 and $4,436, respectively.

Fair value measurements

Fair value measurements	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair value measurements	Fair value measurements The Company measures certain financial assets and liabilities, including derivative instruments, at fair value on a recurring basis. The fair value measurements of these financial assets and liabilities were determined using the following inputs as of December 31, 2023 and September 30, 2024: As of December 31, 2023 Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Significant Total (Level 1) (Level 2) (Level 3) Assets Derivative instruments (Note a, c) $ 22,307 $ — $ 22,307 $ — Deferred compensation plan assets (Note a, d) 51,983 — — 51,983 Total $ 74,290 $ — $ 22,307 $ 51,983 Liabilities Derivative instruments (Note b, c) 17,363 — 17,363 — Deferred compensation plan liability (Note b, e) 51,354 — — 51,354 Total $ 68,717 $ — $ 17,363 $ 51,354 4. Fair value measurements (Continued) As of September 30, 2024 Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Significant Total (Level 1) (Level 2) (Level 3) Assets Derivative instruments (Note a, c) $ 15,324 $ — $ 15,324 $ — Deferred compensation plan assets (Note a, d) 60,991 — — 60,991 Total $ 76,315 $ — $ 15,324 $ 60,991 Liabilities Derivative instruments (Note b, c) 35,067 — 35,067 — Deferred compensation plan liability (Note b, e) 60,354 — — 60,354 Total $ 95,421 $ — $ 35,067 $ 60,354 (a) Derivative assets are included in “prepaid expenses and other current assets” and “other assets” in the consolidated balance sheets. Deferred compensation plan assets are included in “other assets” in the consolidated balance sheets. (b) Included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets. (c) The Company values its derivative instruments based on market observable inputs, including both forward and spot prices for the relevant currencies and interest rate indices for relevant interest rates. The quotes are taken from an independent market database. (d) Deferred compensation plan assets consist of life insurance policies held under a Rabbi Trust. Assets held in the Rabbi Trust are valued based on the cash surrender value of the insurance contract, which is determined based on the fair value of the underlying assets included in the insurance portfolio and are therefore classified within level 3 of the fair value hierarchy. (e) The fair value of the deferred compensation plan liability is derived based on the fair value of the underlying assets in the insurance policies and is therefore classified within level 3 of the fair value hierarchy. The following table provides a roll-forward of the fair value of earn-out consideration categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ — $ — $ 2,517 $ — Payments made on earn-out consideration — — (2,399) — Change in fair value of earn-out consideration (Note a) — — (118) — Closing balance $ — $ — $ — $ — (a) Changes in the fair value of earn-out consideration are reported in “other operating (income) expense, net” in the consolidated statements of income. 4. Fair value measurements (Continued) The following table provides a roll-forward of the fair value of deferred compensation plan assets categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ 47,975 $ 56,992 $ 40,261 $ 51,983 Additions (net of redemption) 555 747 3,752 1,547 Change in fair value of deferred compensation plan assets (Note a) (1,586) 3,252 2,931 7,461 Closing balance $ 46,944 $ 60,991 $ 46,944 $ 60,991 (a) Changes in the fair value of plan assets are reported in “other income (expense), net” in the consolidated statements of income. The following table provides a roll-forward of the fair value of deferred compensation liabilities categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ 47,313 $ 56,311 $ 39,654 $ 51,354 Additions (net of redemption) 555 746 3,752 1,547 Change in fair value of deferred compensation plan liabilities (Note a) (1,536) 3,297 2,926 7,453 Closing balance $ 46,332 $ 60,354 $ 46,332 $ 60,354 (a) Changes in the fair value of deferred compensation plan liabilities are reported in “selling, general and administrative expenses” in the consolidated statements of income.

Derivative financial instrument

Derivative financial instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative financial instruments	Derivative financial instruments The Company is exposed to the risk of rate fluctuations on its foreign currency assets and liabilities and on foreign currency denominated forecasted cash flows and interest rates. The Company has established risk management policies, including the use of derivative financial instruments to hedge foreign currency assets and liabilities, foreign currency denominated forecasted cash flows and interest rate risk. These derivative financial instruments consist of deliverable and non-deliverable forward foreign exchange contracts, treasury rate locks and interest rate swaps. The Company enters into these contracts with counterparties that are banks or other financial institutions, and the Company considers the risk of non-performance by such counterparties not to be material. The forward foreign exchange contracts and interest rate swaps mature during a period of up to 51 months and the forecasted transactions are expected to occur during the same period. The following table presents the aggregate notional principal amounts of outstanding derivative financial instruments together with the related balance sheet exposure: Notional principal amounts (Note a) Balance sheet exposure asset (liability) (Note b) As of December 31, 2023 As of September 30, 2024 As of December 31, 2023 As of September 30, 2024 Foreign exchange forward contracts denominated in: United States Dollars (sell) Indian Rupees (buy) $ 1,892,800 $ 2,385,500 $ 5,278 $ 66 United States Dollars (sell) Mexican Peso (buy) 66,000 71,750 2,129 (6,907) United States Dollars (sell) Philippines Peso (buy) 118,500 136,650 637 (4) Euro (sell) United States Dollars (buy) 222,363 233,085 (3,499) (3,822) Euro (sell) Romanian Leu (buy) 66,384 16,740 90 296 Japanese Yen (sell) Chinese Renminbi (buy) 52,562 44,648 803 1,528 United States Dollars (sell) Chinese Renminbi (buy) 40,800 52,800 (638) (369) Pound Sterling (sell) United States Dollars (buy) 14,915 7,537 (398) (495) United States Dollars (sell) Hungarian Font (buy) 32,000 29,250 809 538 Australian Dollars (sell) Indian Rupees (buy) 90,077 123,127 (1,914) (5,451) United States Dollars (sell) Polish Zloty (buy) 51,000 47,250 3,046 2,165 Japanese Yen (sell) United States Dollars (buy) 7,000 7,000 323 121 Israeli Shekel (buy) United States Dollars (sell) 15,000 15,000 1,175 (53) South African Rand (sell) United States Dollars (buy) 27,000 27,000 216 (3,087) United States Dollars (sell) Brazilian Real (buy) 4,000 4,000 55 (29) United States Dollars (sell) Costa Rica Colon (buy) 13,000 13,000 555 67 United States Dollars (sell) Canadian Dollar (buy) — 9,000 — (46) Pound Sterling (buy) United States Dollar (sell) 22,300 — 669 — United States Dollars (sell) Malaysian Ringgit (buy) 18,000 4,500 161 523 Interest rate swaps (floating to fixed) 148,125 237,500 (4,553) (4,784) $ 4,944 $ (19,743) (a) Notional amounts are key elements of derivative financial instrument agreements but do not represent the amount exchanged by counterparties and do not measure the Company’s exposure to credit, foreign exchange, interest rate or market risks. However, the amounts exchanged are based on the notional amounts and other provisions of the underlying derivative financial instrument agreements. Notional amounts are denominated in U.S. dollars. (b) Balance sheet exposure is denominated in U.S. dollars and denotes the mark-to-market impact of the derivative financial instruments on the reporting date. 5. Derivative financial instruments (Continued) FASB guidance on derivatives and hedging requires companies to recognize all derivative instruments as either assets or liabilities at fair value in the balance sheet. In accordance with FASB guidance on derivatives and hedging, the Company designates foreign exchange forward contracts, interest rate swaps and treasury rate locks as cash flow hedges. Foreign exchange forward contracts are entered into to cover the effects of future exchange rate variability on forecasted revenues and purchases of services, and interest rate swaps and treasury rate locks are entered into to cover interest rate fluctuation risk. In addition to this program, the Company uses derivative instruments that are not accounted for as hedges under FASB guidance in order to hedge foreign exchange risks related to balance sheet items, such as receivables and intercompany borrowings, that are denominated in currencies other than the Company’s underlying functional currency. The fair value of the Company’s derivative instruments and their location in the Company’s financial statements are summarized in the table below: Cash flow hedges Non-designated As of December 31, 2023 As of September 30, 2024 As of December 31, 2023 As of September 30, 2024 Assets Prepaid expenses and other current assets $ 13,273 $ 10,156 $ 5,783 $ 611 Other assets $ 3,251 $ 4,557 $ — $ — Liabilities Accrued expenses and other current liabilities $ 6,833 $ 11,311 $ 1,276 $ 4,896 Other liabilities $ 9,254 $ 18,860 $ — $ — Cash flow hedges For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain (loss) on the derivative instrument is reported as a component of other comprehensive income (loss) and reclassified into earnings in the same period or periods during which the hedged transaction is recognized in the consolidated statements of income. Gains (losses) on the derivatives, representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness, are recognized in earnings as incurred. In March 2021, the Company executed a treasury rate lock agreement for $350,000 in connection with future interest payments to be made on its senior notes issued in March 2021 by Genpact Luxembourg S.à r.l. (“Genpact Luxembourg”) and Genpact USA, Inc. (“Genpact USA”), both wholly-owned subsidiaries of the Company, and the treasury rate lock was designated as a cash flow hedge. The treasury rate lock agreement was terminated on March 23, 2021 and a deferred gain was recorded in accumulated other comprehensive income. This gain is being amortized to interest expense over the life of the 2021 Senior Notes (as defined below). The remaining gain to be amortized related to the treasury rate lock agreement as of December 31, 2023 and September 30, 2024 was $368 and $247, respectively. In May 2024, the Company executed treasury rate lock agreements for $400,000 in connection with future interest payments to be made on its senior notes issued in June 2024 by Genpact Luxembourg and Genpact USA, and the treasury rate locks were designated as cash flow hedges. These treasury rate lock agreements were terminated on May 30, 2024 and a deferred loss was recorded in accumulated other comprehensive income. This loss is being amortized to interest expense over the life of the 2024 Senior Notes (as defined below). The remaining loss to be amortized related to the treasury rate lock agreements as of September 30, 2024 was $371. 5. Derivative financial instruments (Continued) In connection with cash flow hedges, the gains (losses) recorded as a component of other comprehensive income (loss) (“OCI”), and the related tax effects are summarized below: Three months ended September 30, 2023 2024 Before Tax Net of Before Tax Net of Opening balance $ 21,297 $ (5,368) $ 15,928 $ 11,651 $ (3,927) $ 7,724 Net gains (losses) reclassified into statement of income on completion of hedged transactions 3,595 (946) 2,649 2,696 (755) 1,941 Changes in fair value of effective portion of outstanding derivatives, net (9,872) 1,843 (8,028) (24,537) 7,895 (16,642) Gain (loss) on cash flow hedging derivatives, net (13,467) 2,789 (10,677) (27,233) 8,650 (18,583) Closing balance $ 7,830 $ (2,579) $ 5,251 $ (15,582) $ 4,723 $ (10,859) Nine months ended September 30, 2023 2024 Before Tax Net of Before Tax Net of Opening balance $ (7,255) $ 1,543 $ (5,712) $ 805 $ 146 $ 951 Net gains (losses) reclassified into statement of income on completion of hedged transactions 10,622 (2,698) 7,924 9,241 (2,527) 6,714 Changes in fair value of effective portion of outstanding derivatives, net 25,707 (6,820) 18,887 (7,146) 2,050 (5,096) Gain (loss) on cash flow hedging derivatives, net 15,085 (4,122) 10,963 (16,387) 4,577 (11,810) Closing balance $ 7,830 $ (2,579) $ 5,251 $ (15,582) $ 4,723 $ (10,859) The gains or losses recognized in other comprehensive income (loss) and their effects on financial performance are summarized below: Derivatives in Cash Flow Hedging Relationships Amount of Gain (Loss) recognized in OCI on Derivatives (Effective Portion) Location of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion) Amount of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion) Three months ended September 30, Nine months ended September 30, Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 2023 2024 2023 2024 Forward foreign exchange contracts $ (9,809) $ (22,556) $ 24,076 $ (7,666) Revenue $ (222) $ 414 $ 1,007 $ 1,326 Interest rate swaps $ (63) $ (1,981) $ 1,631 $ 917 Cost of revenue 2,199 1,569 1,301 5,617 Treasury rate lock $ — $ — $ — $ (397) Selling, general and administrative expenses 325 214 212 1,054 Interest expense 1,293 499 8,102 1,244 $ (9,872) $ (24,537) $ 25,707 $ (7,146) $ 3,595 $ 2,696 $ 10,622 $ 9,241 5. Derivative financial instruments (Continued) There were no gains (losses) recognized in the statement of income on the ineffective portion of derivatives designated as cash flow hedges and excluded from effectiveness testing for the three and nine months ended September 30, 2023 and 2024, respectively. Non-designated Hedges Amount of Gain (Loss) recognized in Statement of Income on Derivatives Three months ended September 30, Nine months ended September 30, Derivatives not designated as hedging instruments Location of Gain (Loss) recognized in Statement of Income on Derivatives 2023 2024 2023 2024 Forward foreign exchange contracts (Note a) Foreign exchange gains (losses), net $ (5,689) $ (3,473) $ 8,034 $ (3,908) $ (5,689) $ (3,473) $ 8,034 $ (3,908) (a) These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet items such as receivables and intercompany borrowings and were not originally designated as hedges under FASB guidance on derivatives and hedging. Realized gains (losses) and changes in the fair value of these derivatives are recorded in foreign exchange gains, net in the consolidated statements of income.

Prepaid expenses and other curr

Prepaid expenses and other current assets	9 Months Ended
	Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses and other current assets	Prepaid expenses and other current assets Prepaid expenses and other current assets consist of the following: As of December 31, 2023 As of September 30, 2024 Advance income and non-income taxes $ 90,136 $ 60,443 Contract asset (Note 19) 17,454 19,433 Prepaid expenses 36,196 49,429 Derivative instruments (Note 5) 19,056 10,767 Employee advances 5,087 2,633 Deposits 4,406 5,446 Advances to suppliers 1,689 2,208 Others 17,542 13,705 Total $ 191,566 $ 164,064

Assets and liabilities held for

Assets and liabilities held for sale	9 Months Ended
	Sep. 30, 2024
Discontinued Operations and Disposal Groups [Abstract]
Assets and liabilities held for sale	Assets and liabilities held for sale During the year ended December 31, 2022, the Company took actions to realign its portfolio to focus on services it believes have the greatest opportunities for growth, and deprioritized assets that no longer fit with its long-term strategy. Pursuant to a plan approved by management in the second quarter of 2022, the Company identified and divested a business (the “Business”) that was part of the Company's Consumer and Healthcare segment. The transaction to divest the Business included the sale of 100% of the issued and outstanding shares of capital stock of an entity pursuant to a stock purchase agreement, which was completed in December 2022. It also included the sale of certain assets and liabilities pursuant to an asset purchase agreement signed during the fourth quarter of 2022. The sale of such assets was completed in February 2023. 7. Assets and liabilities held for sale (Continued) Pursuant to the stock purchase agreement related to the sale of the Business, the Company was entitled to a potential earn-out of up to $10,600, contingent upon the Business signing contracts with certain clients and invoicing them during 2023. The Company determined that the likelihood of achieving these events was uncertain, and accordingly, the Company opted to record the earn-out if and when the consideration was determined to be realizable. During the year ended December 31 2023, the Company did not receive any earn-out consideration under the stock purchase agreement as the earn-out events were not achieved. Accordingly, the Company did not record any income from earn-out consideration. Pursuant to the asset purchase agreement signed in 2022 related to the sale of the Business, the Company held a 1.5% fixed rate unsecured loan note amounting to $18,001 issued by the buyer group. The Company's obligation to transfer $18,001 to the buyer group in exchange for the note was satisfied in February 2023 upon the closing of the transaction. The note and interest thereon were to become receivable by the Company upon a future share sale, disposal or listing by the buyer group or early voluntary repayment of the note at the discretion of the buyer group. The Company previously deemed the likelihood of recovery of principal and interest on the note to be remote and not in the control of the Company. Accordingly, the Company did not record a value for the note. In November 2023, the Company and the buyer group signed a supplemental deed amending the loan note. Under the supplemental deed, the redemption period was shortened to six months from the execution of the supplemental deed, and the redemption sum was reduced to $1,500. However, under the terms of the supplemental deed, if the Company did not receive the payment of the redemption sum within the revised six month redemption period, the loan note would remain in full force and effect under its original terms and value without modification or amendment under the supplemental deed. In March 2024, the note was redeemed by the buyer group and the Company received the redemption sum of $1,500 against the loan note. The redemption sum received has been recorded in "other operating (income) expense, net" in the Company's consolidated statement of income. See Note 20 for additional information. The Company completed the sale of the Business in February 2023, resulting in a net payout of $2,091 and a loss of $802 on the sale of the Business in the three months ended March 31, 2023, in addition to an impairment charge of $32,575 recorded in the year ended December 31, 2022. However, the Company recorded a gain of $1,500 in the three months ended March 31, 2024 upon the buyer group's redemption of the loan note as described above. The loss (gain) on the sale of the Business has been recorded in "other operating (income) expense, net" in the Company's consolidated statement of income. See Note 20 for additional information.

Property, plant and equipment,

Property, plant and equipment, net	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Property, plant and equipment, net	Property, plant and equipment, net The following table provides the gross and net amount of property, plant and equipment: As of December 31, 2023 As of September 30, 2024 Property, plant and equipment, gross $ 780,134 $ 820,082 Less: Accumulated depreciation and amortization (590,331) (612,490) Property, plant and equipment, net $ 189,803 $ 207,592

Goodwill and intangible assets

Goodwill and intangible assets	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and intangible assets	Goodwill and intangible assets The following table presents the changes in goodwill for the year ended December 31, 2023 and the nine months ended September 30, 2024: For the year ended December 31, 2023 For the nine months ended September 30, 2024 Opening balance 1,684,196 1,683,782 Effect of exchange rate fluctuations (414) (729) Closing balance 1,683,782 1,683,053 The following table presents the changes in goodwill by reporting unit for the year ended December 31, 2023: Financial Services Consumer and Healthcare High Tech and Manufacturing Total Opening balance 408,736 592,907 682,553 1,684,196 Effect of exchange rate fluctuations (62) (127) (225) (414) Closing balance 408,674 592,780 682,328 1,683,782 The following table presents the changes in goodwill by reporting unit for the nine months ended September 30, 2024: Financial Services Consumer and Healthcare High Tech and Manufacturing Total Opening balance 408,674 592,780 682,328 1,683,782 Effect of exchange rate fluctuations (120) (229) (380) (729) Closing balance 408,554 592,551 681,948 1,683,053 The total amount of goodwill deductible for tax purposes was $263,910 and $242,481 as of December 31, 2023 and September 30, 2024, respectively. The Company’s intangible assets are as follows: As of December 31, 2023 As of September 30, 2024 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer-related intangible assets $ 474,090 $ 436,104 $ 37,986 $ 474,310 $ 451,902 $ 22,408 Marketing-related intangible assets 97,840 88,648 9,192 97,855 92,552 5,303 Technology-related intangible assets 129,600 123,750 5,850 131,304 125,678 5,626 $ 701,530 $ 648,502 $ 53,028 $ 703,469 $ 670,132 $ 33,337 Amortization expenses for intangible assets acquired as part of a business combination and disclosed in the consolidated statements of income under amortization of acquired intangible assets for the three months ended September 30, 2023 and 2024 were $7,497 and $6,495, respectively, and for the nine months ended September 30, 2023 and 2024 were $24,009 and $19,980, respectively. 9. Goodwill and intangible assets (Continued) Amortization expenses for internally-developed and other intangible assets disclosed in the consolidated statements of income under cost of revenue and selling, general and administrative expenses for the three months ended September 30, 2023 and 2024 were $2,092 and $534, respectively, and for the nine months ended September 30, 2023 and 2024 were $6,465 and $1,490, respectively. During the three and nine months ended September 30, 2023 and 2024, the Company tested for recoverability certain customer-related and technology-related intangible assets, including those under development, and certain property, plant and equipment, as a result of changes in market trends and the Company’s investment strategy, including the Company's decision to cease certain service offerings. Based on the results of this testing, the Company determined that the carrying values of the assets tested were recoverable. There was no impairment expense recorded in the three and nine months ended September 30, 2023 and 2024.

Short-term borrowings

Short-term borrowings	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Short-term borrowings	Short-term borrowings The Company has the following borrowing facilities: a. Fund-based and non-fund-based credit facilities with banks, which are available for operational requirements in the form of overdrafts, letters of credit, guarantees and short-term loans. As of December 31, 2023 and September 30, 2024, the limits available were $23,302 and $22,893, respectively, of which $9,336 and $8,768, respectively, was utilized, constituting non-funded drawdown. b. A fund-based and non-fund based revolving credit facility of $650,000, which the Company obtained by entering into an amended and restated credit agreement (the "2022 Credit Agreement") with Genpact USA, Genpact Global Holdings (Bermuda) Limited (“GGH”) and Genpact Luxembourg, each wholly-owned subsidiaries of the Company (Genpact Luxembourg, Genpact USA and GGH, collectively, the “Borrowers”), as borrowers, Wells Fargo Bank, National Association (“Wells Fargo”), as administrative agent, swingline lender and issuing bank, and the lenders and other parties thereto on December 13, 2022. The term loan and revolving credit facility under the 2022 Credit Agreement expire on December 13, 2027. Borrowings under the 2022 Credit Agreement bear interest at a rate equal to, at the election of the Company, either Adjusted Term SOFR (which is the rate per annum equal to (a) Term SOFR (the forward-looking secured overnight financing rate) plus (b) a Term SOFR Adjustment of 0.10% per annum, but in no case lower than 0.0%) plus an applicable margin equal to 1.375% per annum or a base rate plus an applicable margin equal to 0.375% per annum. The unutilized amount on the revolving credit facility under the 2022 Credit Agreement bore a commitment fee of 0.20% as of December 31, 2023 and September 30, 2024. As of December 31, 2023 and September 30, 2024, a total of $11,627 and $1,532, respectively, was utilized, of which $10,000 and $0, respectively, constituted funded drawdown and $1,627 and $1,532, respectively, constituted non-funded drawdown. The 2022 Credit Agreement contains certain customary covenants, including a maximum leverage covenant and a minimum interest coverage ratio. As of December 31, 2023 and September 30, 2024, the Company was in compliance with the financial covenants of the 2022 Credit Agreement.

Long-term debt

Long-term debt	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Long-term debt	Long-term debt In December 2022, the Company amended its existing credit facility under its amended and restated credit agreement entered into in August 2018 and entered into the 2022 Credit Agreement, which is comprised of a $530,000 term loan and a $650,000 revolving credit facility. The 2022 Credit Agreement is guaranteed by the Company and certain of its subsidiaries. The obligations under the 2022 Credit Agreement are unsecured. Borrowings under the 2022 Credit Agreement bear interest at a rate equal to, at the election of the Company, either Adjusted Term SOFR (which is the rate per annum equal to (a) Term SOFR (the forward-looking secured overnight financing rate) plus (b) a Term SOFR Adjustment of 0.10% per annum, but in no case lower than 0.00%) plus an applicable margin equal to 1.375% per annum or a base rate plus an applicable margin equal to 0.375% per annum, in each case subject to adjustment based on the Borrowers' debt ratings provided by Standard & Poor’s Rating Services and Moody’s Investors Service, Inc. (the "Debt Ratings"). The revolving credit commitments under the 2022 Credit Agreement are subject to a commitment fee equal to 0.20% per annum, subject to adjustment based on the Debt Ratings. The commitment fee accrues on the actual daily amount by which the aggregate revolving commitments exceed the sum of outstanding revolving loans and letter of credit obligations. The 2022 Credit Agreement restricts certain payments, including dividend payments, if there is an event of default under the 2022 Credit Agreement or if the Company is not, or after making the payment would not be, in compliance with certain financial covenants contained in the 2022 Credit Agreement. These covenants require the Company to maintain a net debt to EBITDA leverage ratio of less than 3x and an interest coverage ratio of more than 3x. As of September 30, 2024, the Company was in compliance with the terms of the 2022 Credit Agreement, including all of the financial covenants therein. The Company’s retained earnings are not subject to any restrictions on availability to make dividend payments to shareholders, subject to compliance with the financial covenants described above that are contained in the 2022 Credit Agreement. As of December 31, 2023 and September 30, 2024, the amount outstanding under the Company's term loan, net of debt amortization expense of $1,258 and $997, was $508,867 and $482,628, respectively. Indebtedness under the 2022 Credit Agreement is unsecured. The amount outstanding on the term loan as of September 30, 2024 requires quarterly payments of $6,625, and the balance of the loan is due and payable upon the maturity of the term loan on December 13, 2027. The maturity profile of the term loan outstanding as of September 30, 2024, net of debt amortization expense, is as follows: Year ending Amount 2024 6,540 2025 26,173 2026 26,192 2027 423,723 Total $ 482,628 Genpact Luxembourg issued $400,000 aggregate principal amount of 3.375% senior notes in November 2019 (the “2019 Senior Notes”). The 2019 Senior Notes are fully guaranteed by the Company and Genpact USA. The total debt issuance cost of $2,937 incurred in connection with the 2019 Senior Notes offering is being amortized over the life of the 2019 Senior Notes as an additional interest expense. As of December 31, 2023 and September 30, 2024, the amount outstanding under the 2019 Senior Notes, net of debt amortization expense of $536 and $99, was $399,464 and $399,901, respectively, which is payable on December 1, 2024. 11. Long-term debt (Continued) In March 2021, Genpact Luxembourg and Genpact USA co-issued $350,000 aggregate principal amount of 1.750% senior notes (the “2021 Senior Notes”). The 2021 Senior Notes are fully guaranteed by the Company. The total debt issuance cost of $3,032 incurred in connection with the 2021 Senior Notes is being amortized over the life of the 2021 Senior Notes as additional interest expense. As of December 31, 2023 and September 30, 2024, the amount outstanding under the 2021 Senior Notes, net of debt amortization expense of $1,369 and $917, respectively, was $348,631 and $349,083 , respectively, which is payable on April 10, 2026. In June 2024, Genpact Luxembourg and Genpact USA co-issued $400,000 aggregate principal amount of 6.000% senior notes (the “2024 Senior Notes,” and together with the 2019 Senior Notes and the 2021 Senior Notes, the "Senior Notes"). The 2024 Senior Notes are fully guaranteed by the Company. The total debt issuance cost of $4,395 incurred in connection with the 2024 Senior Notes is being amortized over the life of the 2024 Senior Notes as additional interest expense. As of September 30, 2024, the amount outstanding under the 2024 Senior Notes, net of debt amortization expense of $4,103, was $395,897, which is payable on June 4, 2029. The Company pays interest on (i) the 2019 Senior Notes semi-annually in arrears on June 1 and December 1 of each year, (ii) the 2021 Senior Notes semi-annually in arrears on April 10 and October 10 of each year and (iii) the 2024 Senior Notes semi-annually in arrears on June 4 and December 4 of each year, ending on the maturity dates of December 1, 2024, April 10, 2026 and June 4, 2029, respectively. The Company, at its option, may redeem the Senior Notes at any time in whole or in part, at a redemption price equal to (i) 100% of the principal amount of the notes redeemed, together with accrued and unpaid interest on the redeemed amount, and (ii) if the notes are redeemed prior to, in the case of the 2019 Senior Notes, November 1, 2024, in the case of the 2021 Senior Notes, March 10, 2026, and in the case of the 2024 Senior Notes, May 4, 2029, a specified “make-whole” premium. Additionally, the Company may redeem any series of Senior Notes in whole, but not in part, at any time at a redemption price equal to 100% of the principal amount thereof, together with accrued and unpaid interest to the redemption date, in the event of certain changes in taxation in any jurisdiction (other than the U.S.) having authority to tax the issuers. Upon certain change of control transactions, the applicable issuer or issuers will be required to make an offer to repurchase the Senior Notes at a price equal to 101% of the aggregate principal amount of the Senior Notes, plus accrued and unpaid interest. The interest rate payable on the 2019 and 2021 Senior Notes is subject to adjustment if the credit rating of the 2019 and 2021 Senior Notes is downgraded, up to a maximum increase of 2.0%. The Senior Notes are subject to certain customary covenants, including limitations on the ability of the Company and certain of its subsidiaries to incur debt secured by liens, engage in certain sale and leaseback transactions and consolidate, merge, convey or transfer their assets substantially as an entirety. During the period ended September 30, 2024, the Company and its applicable subsidiaries were in compliance with the covenants under the Senior Notes. A summary of the Company’s long-term debt is as follows: As of December 31, 2023 As of September 30, 2024 Credit facility, net of amortization expenses $ 508,867 $ 482,628 3.375% 2019 Senior Notes, net of debt amortization expenses 399,464 399,901 1.750% 2021 Senior Notes, net of debt amortization expenses 348,631 349,082 6.000% 2024 Senior Notes, net of debt amortization expenses — 395,897 Total $ 1,256,962 $ 1,627,508 Current portion 432,242 426,069 Non-current portion 824,720 1,201,439 Total $ 1,256,962 $ 1,627,508

Accrued expenses and other curr

Accrued expenses and other current liabilities	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities Accrued expenses and other current liabilities consist of the following: As of December 31, 2023 As of September 30, 2024 Accrued expenses $ 165,378 $ 194,692 Accrued employee cost 322,601 280,908 Statutory liabilities 76,022 65,306 Retirement benefits 2,386 1,806 Compensated absences 29,779 31,352 Derivative instruments (Note 5) 8,109 16,207 Contract liabilities (Note 19) 112,435 105,746 Finance leases liability 10,837 9,720 Other liabilities 31,633 41,752 $ 759,180 $ 747,489

Other liabilities

Other liabilities	9 Months Ended
	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Other liabilities	Other liabilities Other liabilities consist of the following: As of December 31, 2023 As of September 30, 2024 Accrued expenses $ 40,866 $ 46,758 Accrued employee cost 3,329 5,460 Retirement benefits 13,947 14,379 Compensated absences 50,214 51,362 Derivative instruments (Note 5) 9,254 18,860 Contract liabilities (Note 19) 59,393 54,277 Finance leases liability 6,874 8,834 Others 51,071 61,288 $ 234,948 $ 261,218

Employee benefit plans

Employee benefit plans	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Employee benefit plans	Employee benefit plans The Company has employee benefit plans in the form of certain statutory and other programs covering its employees. Defined benefit plans In accordance with Indian law, the Company maintains a defined benefit retirement plan covering substantially all of its Indian employees. In accordance with Mexican law, the Company provides termination benefits to all of its Mexican employees. In addition, certain of the Company’s subsidiaries in the Philippines, Israel and Japan sponsor defined benefit retirement programs. Net defined benefit plan costs for the three and nine months ended September 30, 2023 and 2024 include the following components: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Service costs $ 3,781 $ 4,274 $ 11,290 $ 12,891 Interest costs 1,750 1,994 5,221 6,028 Amortization of actuarial loss 166 60 500 182 Expected return on plan assets (1,261) (1,351) (3,781) (4,069) Net defined benefit plan costs $ 4,436 $ 4,977 $ 13,230 $ 15,032 Defined contribution plans During the three and nine months ended September 30, 2023 and 2024, the Company contributed the following amounts to defined contribution plans in various jurisdictions: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 India $ 12,369 $ 14,029 $ 35,407 $ 40,517 U.S. 4,976 4,664 15,199 15,815 U.K. 4,295 4,227 14,457 14,246 China 6,787 7,315 20,309 21,625 Other Regions 4,851 4,487 14,952 14,009 Total $ 33,278 $ 34,722 $ 100,324 $ 106,212 Deferred compensation plan On July 1, 2018, Genpact LLC, a wholly-owned subsidiary of the Company, adopted an executive deferred compensation plan (the “Plan”). Th e Plan provides a select group of U.S.-based members of Company management with the opportunity to defer from 1% to 80% of their base salary and from 1% to 100% of their qualifying bonus compensation (or such other minimums or maximums as determined by the Plan administrator from time to time) pursuant to the terms of the Plan. Participant deferrals are 100% vested at all times. The Plan also allows for discretionary supplemental employer contributions by the Company, in its sole discretion, which will be subject to a two-year vesting schedule (50% vesting on the one-year anniversary of approval of the contribution and 50% vesting on the second year anniversary of approval of the contribution) or such other vesting schedule as determined by the Company. However, no such contributions have been made by the Company to date. 14. Employee benefit plans (Continued) The Plan also provides an option for participants to elect to receive deferred compensation and earnings thereon on either fixed date(s) no earlier than two years following the applicable Plan year (or end of the ap plicable performance period for performance-based bonus c ompensation) or following a separation from service, in each case either in a lump sum or in annual installments over a term of up to 15 years. Participants can elect to change or re-defer their rights to receive the deferred compensation until the 10th anniversary following their separation from service, subject to fulfillment of certain conditions. Each Plan participant’s compensation deferrals are credited or debited with notional investment gains and losses equal to the performance of selected hypothetical investment funds offered under the Plan and elected by the participant. The Company has investments in funds held in Company-owned life insurance policies which are held in a Rabbi Trust that are classified as trading securities. Management determines the appropriate classification of the securities at the time they are acquired and evaluates the appropriateness of such classifications at each balance sheet date. The liability for the deferred compensation plan was $51,354 and $60,354 as of December 31, 2023 and September 30, 2024, respectively, and is included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets. In connection with the administration of the Plan, the Company has purchased Company-owned life insurance policies insuring the lives of certain employees. The cash surrender value of these policies was $51,983 and $60,991 as of December 31, 2023 and September 30, 2024, respectively. The cash surrender value of these insurance policies is included i n “other assets” in the consolidated balance sheets. During the three months ended September 30, 2023 and 2024, the change in the fair value of Plan assets was $(1,586) and $3,252, respectively, and during the nine months ended September 30, 2023 and 2024, the change in the fair value of Plan assets was $2,931 and $7,461, respectively, which is included in “other income (expense), net,” in the consolidated statements of income. During the three months ended September 30, 2023 and 2024, the change in the fair value of deferred compensation liabilities was $(1,536) and $3,297, respectively, and during the nine months ended September 30, 2023 and 2024, the change in the fair value of deferred compensation liabilities was $2,926 and $7,453, respectively, which is included in “selling, general and administrative expenses.”

Stock-based compensation

Stock-based compensation	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Stock-based compensation	Stoc k-based compensation The Company has issued options under the Genpact Limited 2007 Omnibus Incentive Compensation Plan (the “2007 Omnibus Plan”) and the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the “2017 Omnibus Plan”) to eligible persons, including employees, directors and certain other persons associated with the Company. Under the 2007 Omnibus Plan, shares underlying options forfeited, expired, terminated or cancelled under any of the Company’s predecessor plans were added to the number of shares otherwise available for grant under the 2007 Omnibus Plan. The 2007 Omnibus Plan was amended and restated on April 11, 2012 to increase the number of common shares authorized for issuance by 5,593,200 shares to 15,000,000 shares. Further, during the year ended December 31, 2012, the number of common shares authorized for issuance under the 2007 Omnibus Plan was increased by 8,858,823 shares as a result of a one-time adjustment to outstanding unvested share awards in connection with a special dividend payment. On May 9, 2017, the Company’s shareholders approved the adoption of the 2017 Omnibus Plan, pursuant to which 15,000,000 Company common shares are available for issuance. The 2017 Omnibus Plan was amended and restated on April 5, 2019 and April 5, 2022 to increase the number of common shares authorized for issuance by 8,000,000 shares to 23,000,000 shares and by 3,500,000 shares to 26,500,000 shares, respectively. No grants may be made under the 2007 Omnibus Plan after the date of adoption of the 2017 Omnibus Plan. Grants that were outstanding under the 2007 Omnibus Plan as of the date of the Company’s adoption of the 2017 Omnibus Plan remain subject to the terms of the 2007 Omnibus Plan. Stock-based compensation costs relating to the foregoing plans during the three months ended September 30, 2023 and 2024 were $22,007 and $19,516, respectively, and for the nine months ended September 30, 2023 and 2024 were $62,692 and $46,381, respectively. These costs have been allocated to “cost of revenue” and “selling, general and administrative expenses.” Stock options All options granted under the 2007 Omnibus Plan and 2017 Omnibus Plan are exercisable into common shares of the Company, have a contractual period of ten years and vest over three Compensation cost is determined at the date of grant by estimating the fair value of an option using the Black-Scholes option-pricing model. No options were granted in the nine months ended September 30, 2023 and September 30, 2024. 15. Stoc k-based compensation (Continued) A summary of stock option activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Shares Weighted Weighted average remaining contractual life (years) Aggregate Outstanding as of January 1, 2024 5,998,148 35.77 5.5 — Granted — — — — Forfeited (226,691) 45.13 — — Expired (183,810) 45.19 — — Exercised (135,051) 29.11 — 519 Outstanding as of September 30, 2024 5,452,596 35.23 4.6 34,216 Vested as of September 30, 2024 and expected to vest thereafter (Note a) 5,328,363 34.96 4.6 34,216 Vested and exercisable as of September 30, 2024 4,321,836 32.32 4.1 34,216 Weighted average grant date fair value of grants during the period — (a) Options expected to vest reflect an estimated forfeiture rate. As of September 30, 2024, the total remaining unrecognized stock-based compensation cost for options expected to vest amounted to $5,662, which will be recognized over the weighted average remaining requisite vesting period of 1.7 years. 15. Stoc k-based compensation (Continued) Restricted share units The Company has granted restricted share units (“RSUs”) under the 2007 Omnibus Plan and 2017 Omnibus Plan. Each RSU represents the right to receive one common share. The fair value of each RSU is the market price of one common share of the Company on the date of grant. The RSUs granted to date have graded vesting schedules of three months to four years. The compensation expense is recognized on a straight-line basis over the vesting term. A summary of RSU activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Number of Restricted Share Units Weighted Average Grant Date Fair Value Outstanding as of January 1, 2024 1,036,616 42.87 Granted 1,788,839 34.13 Vested (Note a) (385,515) 41.75 Forfeited (219,258) 39.58 Outstanding as of September 30, 2024 2,220,682 36.34 Expected to vest (Note b) 2,020,866 (a) 385,515 RSUs vested during the nine months ended September 30, 2024, in respect of which 256,393 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2024. (b) The number of RSUs expected to vest reflects the application of an estimated forfeiture rate. 9,103 RSUs vested in the year ended December 31, 2023, in respect of which 4,983 shares were issued during the nine months ended September 30, 2024 after withholding shares to the extent of minimum statutory withholding taxes. 46,358 RSUs vested in the year ended December 31, 2022, in respect of which 45,922 shares were issued during the nine months ended September 30, 2024 after withholding shares to the extent of minimum statutory withholding taxes. As of September 30, 2024, the total remaining unrecognized stock-based compensation cost related to RSUs amounted to $52,495, which will be recognized over the weighted average remaining requisite vesting period of 1.9 years. Performance units The Company also grants stock awards in the form of performance units (“PUs”) and has granted PUs under both the 2007 Omnibus Plan and 2017 Omnibus Plan. Each PU represents the right to receive one common share at a future date based on the Company’s performance against specified targets. PUs granted to date have vesting schedules of approximately six months to three years. PUs granted under the plans are subject to cliff vesting. The compensation expense for such awards is recognized on a straight-line basis over the vesting terms. For PUs granted prior to 2023, the fair value of each PU is the market price of one common share of the Company on the date of grant and assumes that performance targets will be achieved. For PUs that have a performance period of one year, the Company’s estimate of the number of shares to be issued is adjusted upward or downward based upon the probability of achievement of the performance targets. The ultimate number of shares issued and the related compensation cost recognized is based on a comparison of the final performance metrics to the specified targets. 15. Stoc k-based compensation (Continued) For the PUs granted annually beginning in 2023, the performance period of the awards has been increased to three years from one year. The number of PUs that will ultimately vest under the PU awards granted in 2023 and 2024 will be determined, subject to certain conditions and limitations, based on the Company’s achievement of the performance targets set forth in the awards as well as its total shareholder return ("TSR") relative to the TSR of the companies included as of the beginning of the performance period in the S&P 400 Midcap Index (the “Peer Group”) over the three-year performance period. The grant date fair value for PUs granted in 2023 and 2024 is determined using a Monte Carlo simulation model. This model simulates a range of possible future share prices and estimates the probabilities of the potential payouts. This model also incorporates the following assumptions: • The historical volatility for the companies in the Peer Group was measured using the most recent three-year period. • The risk-free interest rate is based on the U.S. Treasury rate assumption commensurate with the three-year performance period. • For determining the TSR of the Company and the companies in the Peer Group, dividends will be assumed to have been reinvested in the stock of the issuing entities on a continuous basis. • The correlation coefficients used to model the way in which each entity tends to move in relation to each other are based upon the price data used to calculate historical volatility. The fair value of each PU granted to employees in the nine months ended September 30, 2024 was estimated on the date of grant using the following valuation assumptions: Nine months ended September 30, 2024 Dividend yield 1.62% - 1.81% Expected life (years) 2.38 - 2.80 Risk-free rate for expected life 3.83% - 4.37% Volatility for expected life 24.24% - 26.33% A summary of PU activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Number of Performance Units Weighted Average Grant Date Fair Value Maximum Shares Eligible to Receive Outstanding as of January 1, 2024 3,649,599 44.32 4,977,057 Granted 1,368,029 32.58 3,283,270 Vested (Note a) (1,362,776) 44.13 (1,362,776) Forfeited (356,375) 42.25 (618,831) Outstanding as of September 30, 2024 3,298,477 39.75 6,278,720 Expected to vest (Note b) 3,352,715 (a) 1,362,776 PUs vested during the nine months ended September 30, 2024, in respect of which 869,713 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2024. (b) The number of PUs expected to vest reflects the application of an estimated forfeiture rate. 15. Stoc k-based compensation (Continued) As of September 30, 2024, the total remaining unrecognized stock-based compensation cost related to PUs amounted to $63,365, which will be recognized over the weighted average remaining requisite vesting period of 2.1 years. Employee Stock Purchase Plan (ESPP) On May 1, 2008, the Company adopted the Genpact Limited U.S. Employee Stock Purchase Plan and the Genpact Limited International Employee Stock Purchase Plan (together, the “ESPP”). In April 2018, these plans were amended and restated, and their terms were extended to August 31, 2028. The ESPP allows eligible employees to purchase the Company’s common shares through payroll deductions at 90% of the closing price of the Company’s common shares on the last business day of each purchase interval. The dollar amount of common shares purchased under the ESPP may not exceed 15% of the participating employee’s base salary, subject to a cap of $25 per employee per calendar year. With effect from September 1, 2009, the offering periods commence on the first business day in March, June, September and December of each year and end on the last business day of the subsequent May, August, November and February. 4,200,000 common shares have been reserved for issuance in the aggregate over the term of the ESPP. During the nine months ended September 30, 2023 and 2024, 255,123 and 261,281 common shares, respectively, were issued under the ESPP. The ESPP is considered compensatory under FASB guidance on Compensation-Stock Compensation. The compensation expense for the ESPP is recognized in accordance with FASB guidance on Compensation-Stock Compensation. The compensation expense for the ESPP during the three months ended September 30, 2023 and 2024 was $307 and $210, respectively, and for the nine months ended September 30, 2023 and 2024 was $1,158 and $895, respectively, and has been allocated to cost of revenue and selling, general and administrative expenses.

Capital stock

Capital stock	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Capital stock	Capital stock Share repurchases The Board of Directors of the Company (the “Board”) has authorized repurchases of up to $2,250,000 under the Company’s existing share repurchase program. Under the program, shares may be purchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2023 and 2024, the Company repurchased 3,828,084 and 4,720,308 of its common shares, respectively, on the open market at a weighted average price of $39.31 and $35.50 per share, respectively, for an aggregate cash amount of $150,471 and $167,562, respectively. All repurchased shares have been retired. The Company records repurchases of its common shares on the settlement date of each transaction. Shares purchased and retired are deducted to the extent of their par value from common shares and from retained earnings for the excess over par value. Direct costs incurred to acquire the shares are included in the total cost of the shares purchased. For the nine months ended September 30, 2023 and 2024, retained earnings were reduced by the direct costs, including taxes, related to share repurchases of $677 and $294, respectively. $231,983 remained available for share repurchases under the Company’s existing share repurchase program as of September 30, 2024. This repurchase program does not obligate the Company to acquire any specific number of shares and does not specify an expiration date. 16. Capital stock (Continued) Dividend On February 9, 2023, the Company announced that its Board had approved a 10% increase in its quarterly cash dividend to $0.1375 per share, up from $0.125 per share in 2022, representing an annual dividend of $0.55 per common share, up from $0.50 per share in 2022, payable to holders of the Company’s common shares. On March 24, 2023, June 26, 2023 and September 26, 2023, the Company paid a dividend of $0.1375 per share, amounting to $25,255, $25,031 and $24,944 in the aggregate, to shareholders of record as of March 10, 2023, June 9, 2023 and September 8, 2023, respectively. On February 8, 2024, the Company announced that its Board had approved an 11% increase in its quarterly cash dividend to $0.1525 per share, up from $0.1375 per share in 2023, representing a planned annual dividend of $0.61 per common share, up from $0.55 per share in 2023, payable to holders of the Company’s common shares. On March 26, 2024, June 26, 2024 and September 25, 2024, the Company paid a dividend of $0.1525 per share, amounting to $27,492, $27,337 and $26,939 in the aggregate, to shareholders of record as of March 11, 2024, June 10, 2024, and September 11, 2024, respectively.

Earnings per share

Earnings per share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings per share	Earnings per share The Company calculates earnings per share in accordance with FASB guidance on earnings per share. Basic and diluted earnings per common share give effect to the change in the number of Company common shares outstanding. The calculation of basic earnings per common share is determined by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the respective periods. The potentially dilutive shares, consisting of outstanding options on common shares, RSUs, common shares to be issued under the ESPP and PUs, have been included in the computation of diluted net earnings per share and the number of weighted average shares outstanding, except where the result would be anti-dilutive. The number of shares subject to stock awards outstanding but not included in the computation of diluted earnings per common share because their effect was anti-dilutive is 2,213,546 and 2,510,837 for the nine months ended September 30, 2023 and 2024, respectively, and 2,389,358 and 1,982,664 for the three months ended September 30, 2023 and 2024, respectively. Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Net income $ 117,593 $ 132,818 $ 339,946 $ 371,755 Weighted average number of common shares used in computing basic earnings per common share 181,399,897 177,595,400 182,808,518 179,221,213 Dilutive effect of stock-based awards 2,401,894 2,118,823 2,929,211 1,633,469 Weighted average number of common shares used in computing dilutive earnings per common share 183,801,791 179,714,223 185,737,729 180,854,682 Earnings per common share Basic $ 0.65 $ 0.75 $ 1.86 $ 2.07 Diluted $ 0.64 $ 0.74 $ 1.83 $ 2.06

Segment reporting

Segment reporting	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment reporting	Segment reporting The Company manages various types of business process and information technology services in an integrated manner for clients in various industries and geographic locations. The Company's operating segments are significant strategic business units that align its products and services with how it manages its business, approaches key markets and interacts with its clients. The Company’s reportable segments are as follows: (1) Financial Services, (2) Consumer and Healthcare, and (3) High Tech and Manufacturing. The Company’s Chief Executive Officer, who has been identified as the Chief Operating Decision Maker ("CODM"), reviews operating segment revenue, which is a GAAP measure, and adjusted income from operations ("AOI"), which is a non-GAAP measure. The Company does not allocate, and therefore the CODM does not evaluate, stock-based compensation expenses, amortization and impairment of acquired intangible assets, foreign exchange gain/(losses) (other than those included in income from operations), interest income/(expense), restructuring (expense)/income, acquisition related expenses, any losses or gains from businesses held for sale, including impairment charges, other income/(expense), or income taxes by segment. The Company’s operating assets and liabilities pertain to multiple segments. The Company manages assets and liabilities on a total company basis, not by operating segment, and therefore asset and liabilities information and capital expenditures by operating segment are not presented to the CODM and are not reviewed by the CODM. Adjusted income from operations for “Others” primarily represents the impact of certain under or over-absorption of corporate overheads, and allowance for credit losses, which are not allocated to the Company’s segments for management’s internal reporting purposes. The Company disaggregates its revenue as revenue from either Digital Operations services or Data-Tech-AI services based on the nature of the services provided. During the first quarter of 2024, the Company realigned as Data-Tech-AI services certain services that had previously been designated as Digital Operations services based on the nature of work performed and the mode of delivery for these particular services, which have evolved over time. Accordingly, the Company has updated the classification of revenue derived from Digital Operations services and Data-Tech-AI services for the three and nine months ended September 30, 2023 to present comparable information. See Note 19 for additional information. The CODM continues to review operating segment revenue, which is a GAAP measure, and adjusted income from operations, which is a non-GAAP measure. 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2023 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 138,194 175,293 313,487 52,991 Consumer and Healthcare 180,190 213,729 393,919 62,299 High Tech and Manufacturing 204,986 223,400 428,386 83,102 Net revenues 523,370 612,422 1,135,792 Others (3,398) Total AOI 194,994 Stock-based compensation (22,314) Amortization and impairment of acquired intangible assets (other than included above) (7,495) Foreign exchange gains, net 2,975 Interest income (expense), net (13,255) Income tax expense (37,312) Net income 117,593 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2024 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 158,579 172,973 331,552 58,271 Consumer and Healthcare 197,438 228,627 426,065 74,465 High Tech and Manufacturing 213,403 239,929 453,332 81,180 Net revenues 569,420 641,529 1,210,949 Others (955) Total AOI 212,961 Stock-based compensation (19,726) Amortization and impairment of acquired intangible assets (other than included above) (6,494) Foreign exchange gains, net 1,133 Interest income (expense), net (12,387) Income tax expense (42,669) Net income 132,818 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2023 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 418,219 495,191 913,410 145,291 Consumer and Healthcare 549,760 624,673 1,174,433 177,581 High Tech and Manufacturing 590,300 652,492 1,242,792 217,014 Net revenues 1,558,279 1,772,356 3,330,635 Business held for sale (refer to Note (a) below and Note 7) (490) 1,201 Net revenues (excluding business held for sale - refer to Note (a) below and Note 7) 3,330,145 Others 18,859 Total AOI 559,946 Stock-based compensation (63,850) Amortization and impairment of acquired intangible assets (other than included above) (23,895) Foreign exchange gains, net 3,698 Interest income (expense), net (35,020) Restructuring (expense)/income (refer to Note 24) 4,874 Operating loss from the business classified as held for sale (refer to Note (a) below and Note 7) (1,201) Loss on the sale of business classified as held for sale (refer to Note (a) below and Note 7) (802) Income tax expense (103,804) Net income 339,946 (a) During the second quarter of 2022, the Company's management approved a plan to divest a business that was part of the Company's Consumer and Healthcare segment. The revenues and associated operating losses attributable to this business, including a loss on the sale of this business recorded in the first quarter of 2023, have been excluded from the computation of adjusted operating income margin with effect from April 1, 2022, as management believes that excluding these items provides useful information about the Company's financial performance and underlying business trends. 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2024 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 450,813 506,351 957,164 158,369 Consumer and Healthcare 576,450 676,991 1,253,441 211,987 High Tech and Manufacturing 612,035 695,758 1,307,793 224,819 Net revenues 1,639,298 1,879,100 3,518,398 Others (1,921) Total AOI 593,254 Stock-based compensation (47,276) Amortization and impairment of acquired intangible assets (other than included above) (19,963) Foreign exchange gains, net 4,424 Interest income (expense), net (36,167) Income tax expense (122,517) Net income 371,755

Net revenues

Net revenues	9 Months Ended
	Sep. 30, 2024
Revenues [Abstract]
Net revenues	Net revenues Disaggregation of revenue The Company disaggregates its revenue as revenue from either Digital Operations services or Data-Tech-AI services based on the nature of the services provided. The Company's Digital Operations services embed digital, advanced analytics and cloud-based offerings into its business process outsourcing solutions where the Company transforms and runs its clients’ operations, with an aim to achieve higher levels of end-to-end performance. These services allow enterprises to be more flexible and help them focus on high-value work to better compete in their industries. The Company's Digital Operations solutions also include certain IT support services for legacy applications, including end user computing support and infrastructure production support. The Company's Data-Tech-AI services focus on designing and building solutions that harness the power of technology, data and advanced analytics, AI, and cloud-based software-as-a-service offerings to help transform the Company's clients’ businesses and operations. These services are advisory, implementation and execution in nature. The Company provides consultative advice to clients as well as technology engineering support and migration and optimization of client’s data and technology enterprise infrastructures. Using human-centric design, the Company helps clients build new products and services, creates digital workspaces, and drives customer, client, employee and partner engagement. During the first quarter of 2024, the Company realigned as Data-Tech-AI services certain services that had previously been designated as Digital Operations services based on the nature of work performed and the mode of delivery for these particular services, which have evolved over time. Accordingly, the Company has updated the classification of revenue derived from Digital Operations services and Data-Tech-AI services for the three and nine months ended September 30, 2023 to present comparable information. In the following table, the Company’s revenue is disaggregated by the nature of services provided: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Data-Tech-AI $ 523,370 $ 569,420 $ 1,558,279 $ 1,639,298 Digital Operations 612,422 641,529 1,772,356 1,879,100 Net revenues $ 1,135,792 $ 1,210,949 $ 3,330,635 $ 3,518,398 All three of the Company's segments include revenue from both Data-Tech-AI and Digital Operations services. See Note 18 for additional information. Contract balances Contract assets represent the contract acquisition fees or other upfront fees paid to a customer. Such costs are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and deducted from revenue. The Company’s assessment did not indicate any significant impairment losses on its contract assets for the periods presented. Contract liabilities include that portion of revenue for which payments have been received in advance from customers. The Company also defers revenues attributable to certain process transition activities for which costs have been capitalized by the Company as contract fulfillment costs. Consideration received from customers, if any, relating to such transition activities is also included as part of contract liabilities. The contract liabilities are included within “Accrued expenses and other current liabilities” and “Other liabilities” in the unaudited consolidated balance sheets. The revenues are recognized as (or when) the performance obligation is fulfilled under the contract with the customer. 19. Net revenues (Continued) The following table shows the details of the Company’s contract balances: As of December 31, 2023 As of September 30, 2024 Contract assets (Note a) $ 33,370 $ 36,285 Contract liabilities (Note b) Deferred transition revenue $ 116,577 $ 112,504 Advance from customers $ 55,251 $ 47,519 (a) Included in "prepaid expenses and other current assets" and "other assets" in the consolidated balance sheet. (b) Included in "accrued expenses and other current liabilities" and "other liabilities" in the consolidated balance sheet. Changes in the Company’s contract asset and liability balances during the three and nine months ended September 30, 2023 and 2024 were a result of normal business activity and not materially impacted by any other factors. The amount of revenue recognized during the three months ended September 30, 2023 and 2024 that was included in the Company's contract liabilities balance at the beginning of the period was $55,007 and $53,189, respectively, and the amount of revenue recognized during the nine months ended September 30, 2023 and 2024 that was included in the Company's contract liabilities balance at the beginning of the period was $140,379 and $98,750, respectively. The following table includes estimated revenue expected to be recognized in the future related to remaining performance obligations as of September 30, 2024: Particulars Total Less than 1 year 1-3 years 3-5 years After 5 years Transaction price allocated to remaining performance obligations $ 160,023 $ 105,746 $ 42,193 $ 9,796 $ 2,288 The following table provides details of the Company’s contract cost assets: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Particulars Sales incentive programs Transition activities Sales incentive programs Transition activities Sales incentive programs Transition activities Sales incentive programs Transition activities Opening balance $ 37,556 $ 156,231 $ 40,252 $ 163,150 $ 34,805 $ 181,865 $ 41,964 $ 160,579 Closing balance 38,411 158,718 40,078 160,362 38,411 158,718 40,078 160,362 Amortization 7,446 20,354 7,604 20,060 22,012 68,460 21,286 57,075

Other operating (income) expens

Other operating (income) expense, net	9 Months Ended
	Sep. 30, 2024
Other Income and Expenses [Abstract]
Other operating (income) expense, net	Other operating (income) expense, net Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Loss on the sale of business classified as held for sale (refer to Note 7) $ — $ — $ 802 $ — Gain on termination of lease (refer to Note 24) — — (4,874) — Other operating (income) expense* (91) (22) (593) (5,561) Other operating (income) expense, net $ (91) $ (22) $ (4,665) $ (5,561) *See Note 7 for additional information about other operating (income) expense, net for the nine months ended September 30, 2024.

Interest income (expense), net

Interest income (expense), net	9 Months Ended
	Sep. 30, 2024
Banking and Thrift, Interest [Abstract]
Interest income (expense), net	Interest income (expense), net Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Interest income $ 4,582 $ 10,323 $ 13,005 $ 22,718 Interest expense (17,837) (22,710) (48,025) (58,885) Interest income (expense), net $ (13,255) $ (12,387) $ (35,020) $ (36,167)

Income taxes

Income taxes	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Income taxes	Income taxes The Company determines its tax provision for interim periods using an estimate of its annual effective tax rate adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if its estimated tax rate changes, the Company makes a cumulative adjustment. The Company’s effective tax rate (“ETR”) was 24.3% for the three months ended September 30, 2024, up from 24.1% for the three months ended September 30, 2023. The increase in the Company’s ETR in the three months ended September 30, 2024 was primarily driven by lower discrete benefits in the three months ended September 30, 2024 compared to the three months ended September 30, 2023. The Company’s ETR was 24.8% for the nine months ended September 30, 2024, up from 23.4% for the nine months ended September 30, 2023. The increase in the Company’s ETR in the nine months ended September 30, 2024 was primarily driven by lower tax deductions related to stock-based compensation in the nine months ended September 30, 2024 compared to the nine months ended September 30, 2023. The following table summarizes activities related to the Company’s unrecognized tax benefits for uncertain tax positions for the nine months ended September 30, 2024: Nine months ended September 30, 2024 Opening balance at January 1 $ 19,236 Decrease related to prior year tax positions due to lapse of applicable statute of limitation (37) Decrease related to settlements with taxing authorities (341) Effect of exchange rate changes (87) Closing balance at September 30 $ 18,771 As of December 31, 2023 and September 30, 2024, the Company had unrecognized tax benefits amounting to $19,236 and $18,771, respectively, which, if recognized, would impact the Company’s ETR. As of December 31, 2023 and September 30, 2024, the Company had accrued $3,312 and $3,387, respectively, in interest and $499 and $512, respectively, for penalties relating to unrecognized tax benefits. 22. Income taxes (Continued)

Commitments and contingencies

Commitments and contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies Capital commitments As of December 31, 2023 and September 30, 2024, the Company has committed to spend $15,982 and $33,533, respectively, under agreements to purchase property, plant and equipment. This amount is net of capital advances paid in respect of these purchases. Bank guarantees The Company has outstanding bank guarantees and letters of credit amounting to $10,963 and $10,300 as of December 31, 2023 and September 30, 2024, respectively. Bank guarantees are generally provided to government agencies or for leases. These guarantees may be revoked if the beneficiary suffers any losses or damages through the breach of any of the covenants contained in the agreements governing such guarantees. Other commitments Certain units of the Company’s Indian subsidiaries are established as Software Technology Parks of India units or Special Economic Zone (“SEZ”) units under the relevant regulations issued by the Government of India. These units are exempt from customs and other duties on imported and indigenous capital goods, stores and spares. SEZ units are also exempt from the Indian Goods and Services Tax that was introduced in India in 2017. The Company has undertaken to pay taxes and duties, if any, in respect of capital goods, stores, spares and services consumed duty-free, in the event that certain terms and conditions are not fulfilled. Contingency (a) In February 2019, there was a judicial pronouncement in India with respect to defined contribution benefit payments interpreting certain statutory defined contribution obligations of employees and employers. If applied retrospectively, the interpretation would result in an increase in contributions payable by the Company for past periods for certain of its India-based employees. Due to a lack of interpretive guidance and based on legal advice the Company has obtained on the matter, it is currently impracticable to reliably estimate the timing and amount of any payments the Company may be required to make. Accordingly, the Company will await further clarity to evaluate the amount of a potential provision, if any. (b) The Indian taxing authorities ("ITA") have issued assessment orders to certain subsidiaries of the Company seeking to assess income tax on certain transactions that occurred in 2015. The Company has received demands for potential tax claims related to these orders in an aggregate amount of $110,448, including interest through the date of the orders. This amount excludes penalties or interest accrued since the date of the orders. The Company is pursuing appeals before the relevant appellate authorities in respect of these orders. Further, in respect of a 2015 transaction, the ITA has attempted to revise a previously closed assessment. During 2022, the Income Tax Appellate Tribunal of India (the "Tribunal") ruled in favor of the Company denying the ITA's ability to revise the assessment, and the ITA have appealed this ruling before the Delhi High Court. In January 2023, notwithstanding the Tribunal’s decision in the Company's favor, the ITA issued a revised assessment order to the Company, and in March 2023, this assessment order was struck down by the Tribunal. The ITA have filed an appeal challenging this most recent decision of the Tribunal before the Delhi High Court. The Company believes that it is more likely than not that the Company’s position will ultimately prevail in respect of these transactions. Accordingly, no unrecognized tax benefit has been provided with respect to this matter as of September 30, 2024. (c) In September 2020, the Indian Parliament approved new labor codes, including the Code on Social Security, 2020 (the “Code”), which will impact the Company’s contributions to its defined benefit plans for employees based in India. The Code has not yet been made effective, and the rules for different states are in the process of being framed. The Company has carried out a preliminary evaluation of the impact the Code will have on the Company. The final impact will be assessed after the Code becomes effective and the related rules are published.

Restructuring

Restructuring	9 Months Ended
	Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring The Company has implemented a flexible, hybrid global delivery model in line with the Company's long-term strategy that incorporates a mix of offshore, onshore, near shore, and remote working. As a result, in the second quarter of 2022, the Company determined that certain leases and employee roles were no longer needed and recorded a restructuring charge relating to the abandonment of leased office premises and an employee severance charge. In the second quarter of 2023, the Company successfully terminated a lease agreement involving leased premises that were abandoned as part of the 2022 restructuring. Accordingly, effective upon the lease termination date, the Company recorded a gain in other operating (income) expense of $4,874 in the nine months ended September 30, 2023. There was no restructuring charge in the nine months ended September 30, 2024.

Subsequent events

Subsequent events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent events	Subsequent events Dividend On October 17, 2024, the Company announced that its Board of Directors has declared a dividend for the third quarter of 2024 of $0.1525 per common share, which is payable on December 23, 2024 to shareholders of record as of the close of business on December 9, 2024. The declaration of any future dividends will be at the discretion of the Board of Directors and subject to Bermuda and other applicable laws.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net income	$ 132,818	$ 117,593	$ 371,755	$ 339,946

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	September 13, 2024
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Balkrishan Kalra [Member]
Trading Arrangements, by Individual
Name	Balkrishan Kalra
Title	President and CEO
Expiration Date	September 30, 2025
Arrangement Duration	382 days
Aggregate Available	54,400

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of preparation and principles of consolidation	(a) Basis of preparation and principles of consolidation The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") and the rules and regulations of the Securities and Exchange Commission (the “SEC”) for reporting on Form 10-Q. Accordingly, they do not include certain information and note disclosures required by generally accepted accounting principles for annual financial reporting and should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The accompanying consolidated financial statements reflect all adjustments that management considers necessary for a fair presentation of the results of operations for these periods. The accompanying financial statements have been prepared on a consolidated basis and reflect the financial statements of Genpact Limited, a Bermuda company, and all of its subsidiaries that are more than 50% owned and controlled. When the Company does not have a controlling interest in an entity but exerts significant influence over the entity, the Company applies the equity method of accounting. All intercompany transactions and balances are eliminated in consolidation.
Use of estimates	(b) Use of estimates
Business combinations	(c) Business combinations, goodwill and other intangible assets The Company accounts for its business combinations using the acquisition method of accounting in accordance with Accounting Standard Codification (“ASC”) Topic 805, Business Combinations, by recognizing the identifiable tangible and intangible assets acquired and liabilities assumed, and any non-controlling interest in the acquired business, measured at their acquisition date fair values. Contingent consideration is included within the acquisition cost and is recognized at its fair value on the acquisition date. A liability resulting from contingent consideration is remeasured to fair value as of each reporting date until the contingency is resolved. Changes in fair value are recognized in earnings. All assets and liabilities of the acquired businesses, including goodwill, are assigned to reporting units. Acquisition-related costs are expensed as incurred under selling, general and administrative expenses.
Goodwill	Goodwill represents the cost of acquired businesses in excess of the fair value of identifiable tangible and intangible net assets purchased. Goodwill is not amortized but is tested for impairment at least on an annual basis on December 31, based on a number of factors, including operating results, business plans and future cash flows. The Company performs an assessment of qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Based on the assessment of events or circumstances, the Company performs a quantitative assessment of goodwill impairment if it determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on the quantitative impairment analysis, the carrying value of the goodwill of a reporting unit exceeds the fair value of such goodwill, an impairment loss is recognized in an amount equal to the excess. In addition, the Company performs a qualitative assessment of goodwill impairment between annual tests if an event occurs or circumstances change that would mor e likely than not reduce the fair value of a reporting unit below its carrying amount. See Note 9 for information and related disclosures.
Intangible assets	Intangible assets acquired individually or with a group of other assets or in a business combination and developed internally are carried at cost less accumulated amortization and accumulated impairment loss based on their estimated useful lives as follows: Customer-related intangible assets 1 - 8 years Marketing-related intangible assets 1 - 8 years Technology-related intangible assets 2 - 10 years Intangible assets are amortized over their estimated useful lives using a method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise realized. In business combinations where the fair value of identifiable tangible and intangible net assets purchased exceeds the cost of the acquired business, the Company recognizes the resulting gain under “Other operating (income) expense, net” in the consolidated statements of income. The Company also capitalizes certain software and technology-related development costs incurred in connection with developing or obtaining software or technology for sale/lease to customers when the initial design phase is completed and commercial and technological feasibility has been established. Any development cost incurred before technological feasibility is established is expensed as incurred as research and development costs. Technological feasibility is established upon completion of a detailed design program or, in its absence, completion of a working model. Capitalized software and technology costs include only (i) external direct costs of materials and services utilized in developing or obtaining software and technology and (ii) compensation and related benefits for employees who are directly associated with the project. Costs incurred in connection with developing or obtaining software or technology for sale/lease to customers which are under development and not put to use are disclosed under “intangible assets under development.” Advances paid towards the acquisition of intangible assets outstanding as of each balance sheet date are disclosed under “intangible assets under development.” Capitalized software and technology costs are included in intangible assets under technology-related intangible assets on the Company’s balance sheet and are amortized on a straight-line basis when placed into service over the estimated useful lives of the software and technology. The Company evaluates the remaining useful life of intangible assets that are being amortized at each reporting period wherever events and circumstances warrant a revision to the remaining period of amortization, and the remaining carrying amount of the intangible asset is amortized prospectively over that revised remaining useful life.
Financial instruments and concentration of credit risk	(d) Financial instruments and concentration of credit risk
Accounts receivable	(e) Accounts receivable Accounts receivable are recorded at the invoiced or to be invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company maintains an allowance for current expected credit losses inherent in its accounts receivable portfolio. In establishing the required allowance, management considers historical losses which are adjusted to current market conditions and a reasonable and supportable forecast. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company uses revolving accounts receivable-based facilities in the normal course of business as part of managing its cash flows. The Company accounts for receivables sold under these facilities as a sale of financial assets pursuant to ASC 860 “Transfers and Servicing” and de-recognizes these receivables, as well as the related allowances, from its balance sheets. Generally, the fair value of accounts receivable sold approximates their book value due to their short-term nature, and any gains or losses on the sale of these receivables are recorded at the time of transfer and included under "interest income (expense), net" in the Company’s consolidated statements of income.
Revenue Recognition	(f) Revenue Recognition The Company derives its revenue primarily from business process management services, including analytics, consulting and related digital solutions and information technology services, which are provided primarily on a time-and-material, transaction or fixed-price basis. The Company recognizes revenue upon the transfer of control of promised services to its customers in an amount that reflects the consideration the Company expects to receive in exchange for those services. Revenues from services rendered under time-and-materials and transaction-based contracts are recognized as the services are provided. The Company’s fixed-price contracts include contracts for customization of applications, maintenance and support services. Revenues from these contracts are recognized ratably over the term of the agreement. The Company accrues for revenue and unbilled receivables for services rendered between the last billing date and the balance sheet date. The Company’s contracts with its customers also include incentive payments received for discrete benefits delivered or promised to be delivered to the customer or service level agreements that could result in credits or refunds to the customer. Revenues relating to such arrangements are accounted for as variable consideration when the amount of revenue to be recognized can be estimated to the extent that it is probable that a significant reversal of any incremental revenue will not occur. The Company records deferred revenue attributable to certain process transition activities where such activities do not represent separate performance obligations. Revenues relating to such transition activities are classified under contract liabilities and subsequently recognized ratably over the period in which the related services are performed. Costs relating to such transition activities are fulfillment costs which are directly related to the contract and result in the enhancement of resources. Such costs are expected to be recoverable under the contract and are therefore classified as contract cost assets and recognized ratably over the estimated expected period of benefit under cost of revenue. 2. Summary of significant accounting policies (Continued) Revenues are reported net of value-added tax, business tax and applicable discounts and allowances. Reimbursements of out-of-pocket expenses received from customers have been included as part of revenues. Revenue for performance obligations that are satisfied over time is recognized in accordance with the methods prescribed for measuring progress. The input (cost expended) method has been used to measure progress towards completion as there is a direct relationship between input and the satisfaction of a performance obligation. Provisions for estimated losses, if any, on uncompleted contracts are recorded in the period in which such losses become probable based on the current contract estimates. The Company enters into multiple-element revenue arrangements in which a customer may purchase a combination of products or services. The Company determines whether each product or service promised to a customer is capable of being distinct, and is distinct in the context of the contract. If not, the promised products or services are combined and accounted for as a single performance obligation. In the event of a multiple-element revenue arrangement, the Company allocates the arrangement consideration to separately identifiable performance obligations based on their relative stand-alone selling prices. Certain contracts may include offerings such as sale of licenses, which may be perpetual or subscription-based. Revenue from distinct, non-cancellable, subscription-based licenses is recognized at the point in time it is transferred to the customer. Revenue from any associated maintenance or ongoing support services is recognized ratably over the term of the contract. For a combined software license/services performance obligation, revenue is recognized over the period that the services are performed. All incremental and direct costs incurred for acquiring contracts, such as certain sales commissions, are classified as contract cost assets. Such costs are amortized over the expected period of benefit and recorded under selling, general and administrative expenses. Other upfront fees paid to customers are classified as contract assets. Such fees are amortized over the expected period of benefit and recorded as an adjustment to the transaction price and deducted from revenue.
Leases	(g) Leases At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The Company’s assessment is based on whether: (1) the contract involves the use of a distinct identified asset, (2) the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the term of the contract, and (3) the Company has the right to direct the use of the asset. At the inception of a lease, the consideration in the contract is allocated to each lease component based on its relative standalone price to determine the lease payments. Leases are classified as either finance leases or operating leases. A lease is classified as a finance lease if any one of the following criteria are met: (1) the lease transfers ownership of the asset by the end of the lease term, (2) the lease contains an option to purchase the asset that is reasonably certain to be exercised, (3) the lease term is for a major part of the remaining useful life of the asset or (4) the present value of the lease payments equals or exceeds substantially all of the fair value of the asset. A lease is classified as an operating lease if it does not meet any one of the above criteria. For all leases at the lease commencement date, a ROU asset and a lease liability are recognized. The lease liability represents the present value of the lease payments under the lease. Lease liabilities are initially measured at the present value of the lease payments not yet paid, discounted using the discount rate for the lease at the lease commencement. The lease liabilities are subsequently measured on an amortized cost basis. The lease liability is adjusted to reflect interest on the liability and the lease payments made during the period. Interest on the lease liability is determined as the amount that results in a constant periodic discount rate on the remaining balance of the liability. The ROU asset represents the right to use the leased asset for the lease term. The ROU asset for each lease initially includes the amount of the initial measurement of the lease liability adjusted for any lease payments made to the lessor at or before the commencement date, accrued lease liabilities and any lease incentives received or any initial direct costs incurred by the Company. The ROU asset of finance leases is subsequently measured at cost, less accumulated amortization and any accumulated impairment losses. The ROU asset of operating leases is subsequently measured from the carrying amount of the lease liability at the end of each reporting period, and is equal to the carrying amount of lease liabilities adjusted for (1) unamortized initial direct costs, (2) prepaid/(accrued) lease payments and (3) the unamortized balance of lease incentives received. The carrying value of ROU assets is reviewed for impairment, similar to long-lived assets, whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. The Company has elected to not separate lease and non-lease components for all of its leases and to use the recognition exemptions for lease contracts that, at commencement date, have a lease term of 12 months or less and do not contain a purchase option (“short-term leases”). Significant judgements The Company determines the lease term as the non-cancellable term of the lease, together with any periods covered by an option to extend the lease if it is reasonably certain to be exercised, or any periods covered by an option to terminate the lease, if it is reasonably certain not to be exercised. Under certain of its leases, the Company has a renewal and termination option to lease assets for additional terms between one 2. Summary of significant accounting policies (Continued) The Company has applied an incremental borrowing rate for the purpose of computing lease liabilities based on the remaining lease term and the rates prevailing in the jurisdictions where leases were executed.
Cost of revenue	(h) Cost of revenue Cost of revenue primarily consists of salaries and benefits (including stock-based compensation), recruitment, training and related costs of employees who are directly responsible for the performance of services for customers, their supervisors and certain support personnel who may be dedicated to a particular client or a set of processes. It also includes operational expenses, such as facilities maintenance expenses, travel and living expenses, rent, IT expenses, contract resources with specialized skills who are directly responsible for the performance of services for clients, and other billable costs related to the Company’s clients. It also includes depreciation of property, plant and equipment, and amortization of intangible and ROU assets which are directly related to providing services that generate revenue.
Selling, general and administrative expenses	(i) Selling, general and administrative expenses Selling, general and administrative (“SG&A”) expenses consist of expenses relating to salaries and benefits (including stock-based compensation) as well as costs related to recruitment, training and retention of senior management and other support personnel in enabling functions such as human resources, finance, legal, marketing, sales and sales support, and other support personnel. The operational costs component of SG&A expenses also includes travel and living costs for such personnel. SG&A expenses also include acquisition-related costs, legal and professional fees (which represent the costs of third party legal, tax, accounting and other advisors), investment in research and development, digital technology, advanced automation and robotics, and an allowance for credit losses. It also includes depreciation of property, plant and equipment, and amortization of intangibles and ROU assets other than those included in cost of revenue.
Credit losses	(j) Credit losses An allowance for credit losses is recognized for all debt instruments other than those held at fair value through profit or loss. The Company pools its accounts receivable (other than deferred billings) based on similar risk characteristics in estimating expected credit losses. Credit losses for accounts receivable are based on the roll-rate method, and the Company recognizes a loss allowance based on lifetime expected credit losses at each reporting date. The Company has established a provision matrix based on historical credit loss experience, adjusted for forward-looking factors and the economic environment. The Company believes the most relevant forward-looking factors are economic environment, gross domestic product, inflation rates and unemployment rates for each of the countries in which the Company or its customers operate, and accordingly the Company adjusts historical loss rates based on expected changes in these factors. At every reporting date, observed historical default rates are updated to reflect changes in the Company’s forward-looking estimates. Credit losses for other financial assets and deferred billings are based on the discounted cash flow (“DCF”) method. Under the DCF method, the allowance for credit losses reflects the difference between the contractual cash flows due in accordance with the contract and the present value of the cash flows expected to be collected. The expected cash flows are discounted at the effective interest rate of the financial asset. Such allowances are based on the credit losses expected to arise over the life of the asset which includes consideration of prepayments based on the Company’s expectation as of the balance sheet date. A financial asset is written off when it is deemed uncollectible and there is no reasonable expectation of recovering the contractual cash flows. Expected recoveries of amounts previously written off, not to exceed the aggregate amounts previously written off, are included in determining the allowance at each reporting period.
Impairment of long-lived assets	(k) Impairment of long-lived assets Long-lived assets, including certain intangible assets, to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable. Such assets are required to be tested for impairment if the carrying amount of the assets is higher than the future undiscounted net cash flows expected to be generated by the assets. The impairment amount to be recognized is measured as the amount by which the carrying value of the assets exceeds their fair value. The Company determines fair value by using a discounted cash flow approach.
Assets held for sale	(l) Assets held for sale A long-lived asset (or a disposal group for a long-lived asset comprising a group of assets and related liabilities) is classified as held for sale if it is highly probable that the asset will be recovered through sale rather than continuing use. The Company records assets held for sale at the lower of its carrying value or fair value less costs to sell. The following criteria are used to determine if a business is held for sale: (i) management, having the authority to approve a sale, commits to a plan to sell; (ii) the business is available for immediate sale in its present condition; (iii) an active program to locate a buyer and a plan to sell the business have been initiated; (iv) the sale of the business is probable within one year; (v) the business is being actively marketed for sale at a reasonable price relative to its fair value; and (vi) it is unlikely that the plan to sell will be withdrawn or that significant changes to the plan will be made. In determining the fair value of the assets less costs to sell, the Company considers factors including current sales prices for comparable assets, discounted cash flow projections, third party valuation and any indicative offers. The Company’s assumptions about fair value require significant judgment because the current market is highly sensitive to changes in economic conditions. The Company estimates the fair values of assets held for sale based on current market conditions and assumptions made by management, which may differ from actual results and may result in impairments if market conditions deteriorate. Any impairment loss on the initial classification and subsequent measurement is recognized as an expense. Any subsequent increase in fair value less costs to sell (not exceeding the accumulated impairment loss that has been previously recognized) is recognized in the income statement.
Recently issued accounting pronouncements	(m) Recently issued accounting pronouncements The authoritative bodies release standards and guidance which are assessed by management for impact on the Company’s consolidated financial statements. The following recently released accounting standard has been adopted by the Company: In March 2023, the FASB issued ASU No. 2023-01, “Leases (Topic 842).” This ASU requires a lessee in a common-control lease arrangement to amortize leasehold improvements that it owns over the improvements’ useful life to the common control group, regardless of the lease term, if the lessee continues to control the use of the underlying asset through a lease. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023. The Company adopted this ASU beginning January 1, 2024. The adoption of this ASU did not have a material impact on the Company's consolidated results of operations, cash flows, financial position or disclosures. 2. Summary of significant accounting policies (Continued) The following recently released accounting standards have not yet been adopted by the Company: In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280)." This ASU improves reportable segment disclosure requirements by enhancing disclosures about significant segment expenses. It requires public entities to disclose significant segment expenses, other segment items, and additional measures of segment profit or loss, providing more comprehensive information for investors and stakeholders. The amendments in this ASU are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its disclosures. In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740)." This ASU enhances income tax disclosures by requiring public business entities on an annual basis (1) to disclose specific categories in the rate reconciliation, and (2) to provide additional information for reconciling items that meet a quantitative threshold, i.e., if the effect of those reconciling items is equal to or greater than 5% of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate. It also requires entities to disclose the income taxes paid (net of refunds received), broken out between federal (national), state/local and foreign, as well as the amounts paid to an individual jurisdiction when 5% or more of the total income taxes were paid to such jurisdiction. The amendments in this ASU are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of assessing the impact of this ASU on its disclosures.

Summary of significant accoun_3

Summary of significant accounting policies (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Schedule of estimated useful lives of intangible assets	Intangible assets acquired individually or with a group of other assets or in a business combination and developed internally are carried at cost less accumulated amortization and accumulated impairment loss based on their estimated useful lives as follows: Customer-related intangible assets 1 - 8 years Marketing-related intangible assets 1 - 8 years Technology-related intangible assets 2 - 10 years

Accounts receivable, net of a_2

Accounts receivable, net of allowance for credit losses (Tables)	9 Months Ended
	Sep. 30, 2024
Receivables [Abstract]
Schedule of allowance for credit losses	The following table provides details of the Company’s allowance for credit losses on accounts receivable: Year ended December 31, 2023 Nine months ended September 30, 2024 Opening balance as of January 1 $ 20,442 $ 18,278 Additions (net), charged to income statement 3,081 7,051 Deductions/effect of exchange rate fluctuations (5,245) (10,496) Closing balance $ 18,278 $ 14,833

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of fair value of assets and liabilities, including derivative instruments, at fair value on a recurring basis	The fair value measurements of these financial assets and liabilities were determined using the following inputs as of December 31, 2023 and September 30, 2024: As of December 31, 2023 Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Significant Total (Level 1) (Level 2) (Level 3) Assets Derivative instruments (Note a, c) $ 22,307 $ — $ 22,307 $ — Deferred compensation plan assets (Note a, d) 51,983 — — 51,983 Total $ 74,290 $ — $ 22,307 $ 51,983 Liabilities Derivative instruments (Note b, c) 17,363 — 17,363 — Deferred compensation plan liability (Note b, e) 51,354 — — 51,354 Total $ 68,717 $ — $ 17,363 $ 51,354 4. Fair value measurements (Continued) As of September 30, 2024 Fair Value Measurements at Reporting Date Using Quoted Prices in Significant Significant Total (Level 1) (Level 2) (Level 3) Assets Derivative instruments (Note a, c) $ 15,324 $ — $ 15,324 $ — Deferred compensation plan assets (Note a, d) 60,991 — — 60,991 Total $ 76,315 $ — $ 15,324 $ 60,991 Liabilities Derivative instruments (Note b, c) 35,067 — 35,067 — Deferred compensation plan liability (Note b, e) 60,354 — — 60,354 Total $ 95,421 $ — $ 35,067 $ 60,354 (a) Derivative assets are included in “prepaid expenses and other current assets” and “other assets” in the consolidated balance sheets. Deferred compensation plan assets are included in “other assets” in the consolidated balance sheets. (b) Included in “accrued expenses and other current liabilities” and “other liabilities” in the consolidated balance sheets. (c) The Company values its derivative instruments based on market observable inputs, including both forward and spot prices for the relevant currencies and interest rate indices for relevant interest rates. The quotes are taken from an independent market database. (d) Deferred compensation plan assets consist of life insurance policies held under a Rabbi Trust. Assets held in the Rabbi Trust are valued based on the cash surrender value of the insurance contract, which is determined based on the fair value of the underlying assets included in the insurance portfolio and are therefore classified within level 3 of the fair value hierarchy. (e) The fair value of the deferred compensation plan liability is derived based on the fair value of the underlying assets in the insurance policies and is therefore classified within level 3 of the fair value hierarchy.
Schedule of roll-forward of fair value of earn-out consideration categorized as level 3 in fair value hierarchy	The following table provides a roll-forward of the fair value of earn-out consideration categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ — $ — $ 2,517 $ — Payments made on earn-out consideration — — (2,399) — Change in fair value of earn-out consideration (Note a) — — (118) — Closing balance $ — $ — $ — $ — (a) Changes in the fair value of earn-out consideration are reported in “other operating (income) expense, net” in the consolidated statements of income.
Schedule of roll-forward of fair value of deferred compensation plan assets categorized as level 3 in fair value hierarchy	The following table provides a roll-forward of the fair value of deferred compensation plan assets categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ 47,975 $ 56,992 $ 40,261 $ 51,983 Additions (net of redemption) 555 747 3,752 1,547 Change in fair value of deferred compensation plan assets (Note a) (1,586) 3,252 2,931 7,461 Closing balance $ 46,944 $ 60,991 $ 46,944 $ 60,991 (a)
Roll-forward of fair value of deferred compensation liabilities categorized as Level 3 in fair value hierarchy	The following table provides a roll-forward of the fair value of deferred compensation liabilities categorized as level 3 in the fair value hierarchy for the three and nine months ended September 30, 2023 and 2024: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Opening balance $ 47,313 $ 56,311 $ 39,654 $ 51,354 Additions (net of redemption) 555 746 3,752 1,547 Change in fair value of deferred compensation plan liabilities (Note a) (1,536) 3,297 2,926 7,453 Closing balance $ 46,332 $ 60,354 $ 46,332 $ 60,354 (a) Changes in the fair value of deferred compensation plan liabilities are reported in “selling, general and administrative expenses” in the consolidated statements of income.

Derivative financial instrume_2

Derivative financial instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of aggregate notional principal amounts of outstanding derivative financial instruments with related balance sheet exposure	The following table presents the aggregate notional principal amounts of outstanding derivative financial instruments together with the related balance sheet exposure: Notional principal amounts (Note a) Balance sheet exposure asset (liability) (Note b) As of December 31, 2023 As of September 30, 2024 As of December 31, 2023 As of September 30, 2024 Foreign exchange forward contracts denominated in: United States Dollars (sell) Indian Rupees (buy) $ 1,892,800 $ 2,385,500 $ 5,278 $ 66 United States Dollars (sell) Mexican Peso (buy) 66,000 71,750 2,129 (6,907) United States Dollars (sell) Philippines Peso (buy) 118,500 136,650 637 (4) Euro (sell) United States Dollars (buy) 222,363 233,085 (3,499) (3,822) Euro (sell) Romanian Leu (buy) 66,384 16,740 90 296 Japanese Yen (sell) Chinese Renminbi (buy) 52,562 44,648 803 1,528 United States Dollars (sell) Chinese Renminbi (buy) 40,800 52,800 (638) (369) Pound Sterling (sell) United States Dollars (buy) 14,915 7,537 (398) (495) United States Dollars (sell) Hungarian Font (buy) 32,000 29,250 809 538 Australian Dollars (sell) Indian Rupees (buy) 90,077 123,127 (1,914) (5,451) United States Dollars (sell) Polish Zloty (buy) 51,000 47,250 3,046 2,165 Japanese Yen (sell) United States Dollars (buy) 7,000 7,000 323 121 Israeli Shekel (buy) United States Dollars (sell) 15,000 15,000 1,175 (53) South African Rand (sell) United States Dollars (buy) 27,000 27,000 216 (3,087) United States Dollars (sell) Brazilian Real (buy) 4,000 4,000 55 (29) United States Dollars (sell) Costa Rica Colon (buy) 13,000 13,000 555 67 United States Dollars (sell) Canadian Dollar (buy) — 9,000 — (46) Pound Sterling (buy) United States Dollar (sell) 22,300 — 669 — United States Dollars (sell) Malaysian Ringgit (buy) 18,000 4,500 161 523 Interest rate swaps (floating to fixed) 148,125 237,500 (4,553) (4,784) $ 4,944 $ (19,743) (a) Notional amounts are key elements of derivative financial instrument agreements but do not represent the amount exchanged by counterparties and do not measure the Company’s exposure to credit, foreign exchange, interest rate or market risks. However, the amounts exchanged are based on the notional amounts and other provisions of the underlying derivative financial instrument agreements. Notional amounts are denominated in U.S. dollars. (b) Balance sheet exposure is denominated in U.S. dollars and denotes the mark-to-market impact of the derivative financial instruments on the reporting date.
Schedule of fair value of derivative instruments and their location in the Company's financial statements	The fair value of the Company’s derivative instruments and their location in the Company’s financial statements are summarized in the table below: Cash flow hedges Non-designated As of December 31, 2023 As of September 30, 2024 As of December 31, 2023 As of September 30, 2024 Assets Prepaid expenses and other current assets $ 13,273 $ 10,156 $ 5,783 $ 611 Other assets $ 3,251 $ 4,557 $ — $ — Liabilities Accrued expenses and other current liabilities $ 6,833 $ 11,311 $ 1,276 $ 4,896 Other liabilities $ 9,254 $ 18,860 $ — $ —
Schedule gains (losses) recorded as component of other comprehensive income (loss) in connection with cash flow hedges	In connection with cash flow hedges, the gains (losses) recorded as a component of other comprehensive income (loss) (“OCI”), and the related tax effects are summarized below: Three months ended September 30, 2023 2024 Before Tax Net of Before Tax Net of Opening balance $ 21,297 $ (5,368) $ 15,928 $ 11,651 $ (3,927) $ 7,724 Net gains (losses) reclassified into statement of income on completion of hedged transactions 3,595 (946) 2,649 2,696 (755) 1,941 Changes in fair value of effective portion of outstanding derivatives, net (9,872) 1,843 (8,028) (24,537) 7,895 (16,642) Gain (loss) on cash flow hedging derivatives, net (13,467) 2,789 (10,677) (27,233) 8,650 (18,583) Closing balance $ 7,830 $ (2,579) $ 5,251 $ (15,582) $ 4,723 $ (10,859) Nine months ended September 30, 2023 2024 Before Tax Net of Before Tax Net of Opening balance $ (7,255) $ 1,543 $ (5,712) $ 805 $ 146 $ 951 Net gains (losses) reclassified into statement of income on completion of hedged transactions 10,622 (2,698) 7,924 9,241 (2,527) 6,714 Changes in fair value of effective portion of outstanding derivatives, net 25,707 (6,820) 18,887 (7,146) 2,050 (5,096) Gain (loss) on cash flow hedging derivatives, net 15,085 (4,122) 10,963 (16,387) 4,577 (11,810) Closing balance $ 7,830 $ (2,579) $ 5,251 $ (15,582) $ 4,723 $ (10,859)
Schedule of gains or losses recognized in other comprehensive income (loss)	The gains or losses recognized in other comprehensive income (loss) and their effects on financial performance are summarized below: Derivatives in Cash Flow Hedging Relationships Amount of Gain (Loss) recognized in OCI on Derivatives (Effective Portion) Location of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion) Amount of Gain (Loss) reclassified from OCI into Statement of Income (Effective Portion) Three months ended September 30, Nine months ended September 30, Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 2023 2024 2023 2024 Forward foreign exchange contracts $ (9,809) $ (22,556) $ 24,076 $ (7,666) Revenue $ (222) $ 414 $ 1,007 $ 1,326 Interest rate swaps $ (63) $ (1,981) $ 1,631 $ 917 Cost of revenue 2,199 1,569 1,301 5,617 Treasury rate lock $ — $ — $ — $ (397) Selling, general and administrative expenses 325 214 212 1,054 Interest expense 1,293 499 8,102 1,244 $ (9,872) $ (24,537) $ 25,707 $ (7,146) $ 3,595 $ 2,696 $ 10,622 $ 9,241 Amount of Gain (Loss) recognized in Statement of Income on Derivatives Three months ended September 30, Nine months ended September 30, Derivatives not designated as hedging instruments Location of Gain (Loss) recognized in Statement of Income on Derivatives 2023 2024 2023 2024 Forward foreign exchange contracts (Note a) Foreign exchange gains (losses), net $ (5,689) $ (3,473) $ 8,034 $ (3,908) $ (5,689) $ (3,473) $ 8,034 $ (3,908) (a) These forward foreign exchange contracts were entered into to hedge fluctuations in foreign exchange rates for recognized balance sheet items such as receivables and intercompany borrowings and were not originally designated as hedges under FASB guidance on derivatives and hedging. Realized gains (losses) and changes in the fair value of these derivatives are recorded in foreign exchange gains, net in the consolidated statements of income.

Prepaid expenses and other cu_2

Prepaid expenses and other current assets (Tables)	9 Months Ended
	Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of prepaid expenses and other current assets	Prepaid expenses and other current assets consist of the following: As of December 31, 2023 As of September 30, 2024 Advance income and non-income taxes $ 90,136 $ 60,443 Contract asset (Note 19) 17,454 19,433 Prepaid expenses 36,196 49,429 Derivative instruments (Note 5) 19,056 10,767 Employee advances 5,087 2,633 Deposits 4,406 5,446 Advances to suppliers 1,689 2,208 Others 17,542 13,705 Total $ 191,566 $ 164,064

Property, plant and equipment_2

Property, plant and equipment, net (Tables)	9 Months Ended
	Sep. 30, 2024
Property, Plant and Equipment [Abstract]
Schedule of gross and net amount of property, plant and equipment	The following table provides the gross and net amount of property, plant and equipment: As of December 31, 2023 As of September 30, 2024 Property, plant and equipment, gross $ 780,134 $ 820,082 Less: Accumulated depreciation and amortization (590,331) (612,490) Property, plant and equipment, net $ 189,803 $ 207,592

Goodwill and intangible assets

Goodwill and intangible assets (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in goodwill	The following table presents the changes in goodwill for the year ended December 31, 2023 and the nine months ended September 30, 2024: For the year ended December 31, 2023 For the nine months ended September 30, 2024 Opening balance 1,684,196 1,683,782 Effect of exchange rate fluctuations (414) (729) Closing balance 1,683,782 1,683,053
Schedule of goodwill by reporting unit	The following table presents the changes in goodwill by reporting unit for the year ended December 31, 2023: Financial Services Consumer and Healthcare High Tech and Manufacturing Total Opening balance 408,736 592,907 682,553 1,684,196 Effect of exchange rate fluctuations (62) (127) (225) (414) Closing balance 408,674 592,780 682,328 1,683,782 The following table presents the changes in goodwill by reporting unit for the nine months ended September 30, 2024: Financial Services Consumer and Healthcare High Tech and Manufacturing Total Opening balance 408,674 592,780 682,328 1,683,782 Effect of exchange rate fluctuations (120) (229) (380) (729) Closing balance 408,554 592,551 681,948 1,683,053
Summary of intangible assets	The Company’s intangible assets are as follows: As of December 31, 2023 As of September 30, 2024 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer-related intangible assets $ 474,090 $ 436,104 $ 37,986 $ 474,310 $ 451,902 $ 22,408 Marketing-related intangible assets 97,840 88,648 9,192 97,855 92,552 5,303 Technology-related intangible assets 129,600 123,750 5,850 131,304 125,678 5,626 $ 701,530 $ 648,502 $ 53,028 $ 703,469 $ 670,132 $ 33,337

Long-term debt (Tables)

Long-term debt (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of maturity profile of term loan outstanding net of debt amortization expense	The maturity profile of the term loan outstanding as of September 30, 2024, net of debt amortization expense, is as follows: Year ending Amount 2024 6,540 2025 26,173 2026 26,192 2027 423,723 Total $ 482,628
Summary of long term debt	A summary of the Company’s long-term debt is as follows: As of December 31, 2023 As of September 30, 2024 Credit facility, net of amortization expenses $ 508,867 $ 482,628 3.375% 2019 Senior Notes, net of debt amortization expenses 399,464 399,901 1.750% 2021 Senior Notes, net of debt amortization expenses 348,631 349,082 6.000% 2024 Senior Notes, net of debt amortization expenses — 395,897 Total $ 1,256,962 $ 1,627,508 Current portion 432,242 426,069 Non-current portion 824,720 1,201,439 Total $ 1,256,962 $ 1,627,508

Accrued expenses and other cu_2

Accrued expenses and other current liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Payables and Accruals [Abstract]
Schedule of accrued expenses and other current liabilities	Accrued expenses and other current liabilities consist of the following: As of December 31, 2023 As of September 30, 2024 Accrued expenses $ 165,378 $ 194,692 Accrued employee cost 322,601 280,908 Statutory liabilities 76,022 65,306 Retirement benefits 2,386 1,806 Compensated absences 29,779 31,352 Derivative instruments (Note 5) 8,109 16,207 Contract liabilities (Note 19) 112,435 105,746 Finance leases liability 10,837 9,720 Other liabilities 31,633 41,752 $ 759,180 $ 747,489

Other liabilities (Tables)

Other liabilities (Tables)	9 Months Ended
	Sep. 30, 2024
Other Liabilities Disclosure [Abstract]
Schedule of other liabilities	Other liabilities consist of the following: As of December 31, 2023 As of September 30, 2024 Accrued expenses $ 40,866 $ 46,758 Accrued employee cost 3,329 5,460 Retirement benefits 13,947 14,379 Compensated absences 50,214 51,362 Derivative instruments (Note 5) 9,254 18,860 Contract liabilities (Note 19) 59,393 54,277 Finance leases liability 6,874 8,834 Others 51,071 61,288 $ 234,948 $ 261,218

Employee benefit plans (Tables)

Employee benefit plans (Tables)	9 Months Ended
	Sep. 30, 2024
Retirement Benefits [Abstract]
Schedule of net defined benefit plan costs	Net defined benefit plan costs for the three and nine months ended September 30, 2023 and 2024 include the following components: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Service costs $ 3,781 $ 4,274 $ 11,290 $ 12,891 Interest costs 1,750 1,994 5,221 6,028 Amortization of actuarial loss 166 60 500 182 Expected return on plan assets (1,261) (1,351) (3,781) (4,069) Net defined benefit plan costs $ 4,436 $ 4,977 $ 13,230 $ 15,032
Schedule of amounts contributed to defined contribution plans in various jurisdictions	During the three and nine months ended September 30, 2023 and 2024, the Company contributed the following amounts to defined contribution plans in various jurisdictions: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 India $ 12,369 $ 14,029 $ 35,407 $ 40,517 U.S. 4,976 4,664 15,199 15,815 U.K. 4,295 4,227 14,457 14,246 China 6,787 7,315 20,309 21,625 Other Regions 4,851 4,487 14,952 14,009 Total $ 33,278 $ 34,722 $ 100,324 $ 106,212

Stock-based compensation (Table

Stock-based compensation (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of stock option activity	A summary of stock option activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Shares Weighted Weighted average remaining contractual life (years) Aggregate Outstanding as of January 1, 2024 5,998,148 35.77 5.5 — Granted — — — — Forfeited (226,691) 45.13 — — Expired (183,810) 45.19 — — Exercised (135,051) 29.11 — 519 Outstanding as of September 30, 2024 5,452,596 35.23 4.6 34,216 Vested as of September 30, 2024 and expected to vest thereafter (Note a) 5,328,363 34.96 4.6 34,216 Vested and exercisable as of September 30, 2024 4,321,836 32.32 4.1 34,216 Weighted average grant date fair value of grants during the period — (a) Options expected to vest reflect an estimated forfeiture rate.
Schedule of restricted share units activity	A summary of RSU activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Number of Restricted Share Units Weighted Average Grant Date Fair Value Outstanding as of January 1, 2024 1,036,616 42.87 Granted 1,788,839 34.13 Vested (Note a) (385,515) 41.75 Forfeited (219,258) 39.58 Outstanding as of September 30, 2024 2,220,682 36.34 Expected to vest (Note b) 2,020,866 (a) 385,515 RSUs vested during the nine months ended September 30, 2024, in respect of which 256,393 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2024. (b)
Schedule of significant assumptions used in determining fair value of performance units	The fair value of each PU granted to employees in the nine months ended September 30, 2024 was estimated on the date of grant using the following valuation assumptions: Nine months ended September 30, 2024 Dividend yield 1.62% - 1.81% Expected life (years) 2.38 - 2.80 Risk-free rate for expected life 3.83% - 4.37% Volatility for expected life 24.24% - 26.33%
Schedule of performance units activity	A summary of PU activity during the nine months ended September 30, 2024 is set out below: Nine Months Ended September 30, 2024 Number of Performance Units Weighted Average Grant Date Fair Value Maximum Shares Eligible to Receive Outstanding as of January 1, 2024 3,649,599 44.32 4,977,057 Granted 1,368,029 32.58 3,283,270 Vested (Note a) (1,362,776) 44.13 (1,362,776) Forfeited (356,375) 42.25 (618,831) Outstanding as of September 30, 2024 3,298,477 39.75 6,278,720 Expected to vest (Note b) 3,352,715 (a) 1,362,776 PUs vested during the nine months ended September 30, 2024, in respect of which 869,713 shares (net of minimum statutory tax withholding) were issued during the nine months ended September 30, 2024. (b) The number of PUs expected to vest reflects the application of an estimated forfeiture rate.

Earnings per share (Tables)

Earnings per share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of earnings per share	The number of shares subject to stock awards outstanding but not included in the computation of diluted earnings per common share because their effect was anti-dilutive is 2,213,546 and 2,510,837 for the nine months ended September 30, 2023 and 2024, respectively, and 2,389,358 and 1,982,664 for the three months ended September 30, 2023 and 2024, respectively. Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Net income $ 117,593 $ 132,818 $ 339,946 $ 371,755 Weighted average number of common shares used in computing basic earnings per common share 181,399,897 177,595,400 182,808,518 179,221,213 Dilutive effect of stock-based awards 2,401,894 2,118,823 2,929,211 1,633,469 Weighted average number of common shares used in computing dilutive earnings per common share 183,801,791 179,714,223 185,737,729 180,854,682 Earnings per common share Basic $ 0.65 $ 0.75 $ 1.86 $ 2.07 Diluted $ 0.64 $ 0.74 $ 1.83 $ 2.06

Segment reporting (Tables)

Segment reporting (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of revenue and adjusted income from operations by reporting segments	Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2023 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 138,194 175,293 313,487 52,991 Consumer and Healthcare 180,190 213,729 393,919 62,299 High Tech and Manufacturing 204,986 223,400 428,386 83,102 Net revenues 523,370 612,422 1,135,792 Others (3,398) Total AOI 194,994 Stock-based compensation (22,314) Amortization and impairment of acquired intangible assets (other than included above) (7,495) Foreign exchange gains, net 2,975 Interest income (expense), net (13,255) Income tax expense (37,312) Net income 117,593 Revenues and adjusted income from operations for each of the Company’s segments for the three months ended September 30, 2024 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 158,579 172,973 331,552 58,271 Consumer and Healthcare 197,438 228,627 426,065 74,465 High Tech and Manufacturing 213,403 239,929 453,332 81,180 Net revenues 569,420 641,529 1,210,949 Others (955) Total AOI 212,961 Stock-based compensation (19,726) Amortization and impairment of acquired intangible assets (other than included above) (6,494) Foreign exchange gains, net 1,133 Interest income (expense), net (12,387) Income tax expense (42,669) Net income 132,818 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2023 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 418,219 495,191 913,410 145,291 Consumer and Healthcare 549,760 624,673 1,174,433 177,581 High Tech and Manufacturing 590,300 652,492 1,242,792 217,014 Net revenues 1,558,279 1,772,356 3,330,635 Business held for sale (refer to Note (a) below and Note 7) (490) 1,201 Net revenues (excluding business held for sale - refer to Note (a) below and Note 7) 3,330,145 Others 18,859 Total AOI 559,946 Stock-based compensation (63,850) Amortization and impairment of acquired intangible assets (other than included above) (23,895) Foreign exchange gains, net 3,698 Interest income (expense), net (35,020) Restructuring (expense)/income (refer to Note 24) 4,874 Operating loss from the business classified as held for sale (refer to Note (a) below and Note 7) (1,201) Loss on the sale of business classified as held for sale (refer to Note (a) below and Note 7) (802) Income tax expense (103,804) Net income 339,946 (a) During the second quarter of 2022, the Company's management approved a plan to divest a business that was part of the Company's Consumer and Healthcare segment. The revenues and associated operating losses attributable to this business, including a loss on the sale of this business recorded in the first quarter of 2023, have been excluded from the computation of adjusted operating income margin with effect from April 1, 2022, as management believes that excluding these items provides useful information about the Company's financial performance and underlying business trends. 18. Segment reporting (Continued) Revenues and adjusted income from operations for each of the Company’s segments for the nine months ended September 30, 2024 were as follows: Net revenues Data-Tech-AI Digital operations Total AOI Financial Services 450,813 506,351 957,164 158,369 Consumer and Healthcare 576,450 676,991 1,253,441 211,987 High Tech and Manufacturing 612,035 695,758 1,307,793 224,819 Net revenues 1,639,298 1,879,100 3,518,398 Others (1,921) Total AOI 593,254 Stock-based compensation (47,276) Amortization and impairment of acquired intangible assets (other than included above) (19,963) Foreign exchange gains, net 4,424 Interest income (expense), net (36,167) Income tax expense (122,517) Net income 371,755

Net revenues (Tables)

Net revenues (Tables)	9 Months Ended
	Sep. 30, 2024
Revenues [Abstract]
Schedule of net revenues disaggregated by customer	In the following table, the Company’s revenue is disaggregated by the nature of services provided: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Data-Tech-AI $ 523,370 $ 569,420 $ 1,558,279 $ 1,639,298 Digital Operations 612,422 641,529 1,772,356 1,879,100 Net revenues $ 1,135,792 $ 1,210,949 $ 3,330,635 $ 3,518,398
Schedule of details of contract balances	The following table shows the details of the Company’s contract balances: As of December 31, 2023 As of September 30, 2024 Contract assets (Note a) $ 33,370 $ 36,285 Contract liabilities (Note b) Deferred transition revenue $ 116,577 $ 112,504 Advance from customers $ 55,251 $ 47,519 (a) Included in "prepaid expenses and other current assets" and "other assets" in the consolidated balance sheet. (b) Included in "accrued expenses and other current liabilities" and "other liabilities" in the consolidated balance sheet.
Schedule of estimated revenue expected to be recognized in the future related to remaining performance obligation	The following table includes estimated revenue expected to be recognized in the future related to remaining performance obligations as of September 30, 2024: Particulars Total Less than 1 year 1-3 years 3-5 years After 5 years Transaction price allocated to remaining performance obligations $ 160,023 $ 105,746 $ 42,193 $ 9,796 $ 2,288
Schedule of contract cost assets	The following table provides details of the Company’s contract cost assets: Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Particulars Sales incentive programs Transition activities Sales incentive programs Transition activities Sales incentive programs Transition activities Sales incentive programs Transition activities Opening balance $ 37,556 $ 156,231 $ 40,252 $ 163,150 $ 34,805 $ 181,865 $ 41,964 $ 160,579 Closing balance 38,411 158,718 40,078 160,362 38,411 158,718 40,078 160,362 Amortization 7,446 20,354 7,604 20,060 22,012 68,460 21,286 57,075

Other operating (income) expe_2

Other operating (income) expense, net (Tables)	9 Months Ended
	Sep. 30, 2024
Other Income and Expenses [Abstract]
Schedule of other operating (income) expense, net	Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Loss on the sale of business classified as held for sale (refer to Note 7) $ — $ — $ 802 $ — Gain on termination of lease (refer to Note 24) — — (4,874) — Other operating (income) expense* (91) (22) (593) (5,561) Other operating (income) expense, net $ (91) $ (22) $ (4,665) $ (5,561) *See Note 7 for additional information about other operating (income) expense, net for the nine months ended September 30, 2024.

Interest income (expense), net

Interest income (expense), net (Tables)	9 Months Ended
	Sep. 30, 2024
Banking and Thrift, Interest [Abstract]
Schedule of interest income (expense), net	Three months ended September 30, Nine months ended September 30, 2023 2024 2023 2024 Interest income $ 4,582 $ 10,323 $ 13,005 $ 22,718 Interest expense (17,837) (22,710) (48,025) (58,885) Interest income (expense), net $ (13,255) $ (12,387) $ (35,020) $ (36,167)

Income taxes (Tables)

Income taxes (Tables)	9 Months Ended
	Sep. 30, 2024
Income Tax Disclosure [Abstract]
Schedule of activities related to unrecognized tax benefits for uncertain tax positions	The following table summarizes activities related to the Company’s unrecognized tax benefits for uncertain tax positions for the nine months ended September 30, 2024: Nine months ended September 30, 2024 Opening balance at January 1 $ 19,236 Decrease related to prior year tax positions due to lapse of applicable statute of limitation (37) Decrease related to settlements with taxing authorities (341) Effect of exchange rate changes (87) Closing balance at September 30 $ 18,771

Organization - Narrative (Detai

Organization - Narrative (Detail)	Sep. 30, 2024 Employee Country
Product Information [Line Items]
Number of countries in which entity operates | Country	35
Minimum
Product Information [Line Items]
Number of employees around the globe, minimum | Employee	138,500

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of estimated useful lives of intangible assets (Detail)	Sep. 30, 2024
Customer-related intangible assets | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	1 year
Customer-related intangible assets | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	8 years
Marketing-related intangible assets | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	1 year
Marketing-related intangible assets | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	8 years
Technology-related intangible assets | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	2 years
Technology-related intangible assets | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets estimated useful lives	10 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Narrative (Detail)	9 Months Ended
	Sep. 30, 2024
Minimum
Schedule Of Significant Accounting Policies [Line Items]
Additional terms of termination option	1 year
Maximum
Schedule Of Significant Accounting Policies [Line Items]
Additional terms of termination option	10 years

Accounts receivable, net of a_3

Accounts receivable, net of allowance for credit losses - Schedule of allowance for credit losses (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Receivables [Abstract]
Opening balance as of January 1	$ 18,278	$ 20,442
Additions (net), charged to income statement	7,051	3,081
Deductions/effect of exchange rate fluctuations	(10,496)	(5,245)
Closing balance	$ 14,833	$ 18,278

Accounts receivable, net of a_4

Accounts receivable, net of allowance for credit losses - Narrative (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Gross accounts receivable	$ 1,228,931		$ 1,228,931		$ 1,134,551
Allowance for credit losses	14,833		14,833		18,278	$ 20,442
Accounts receivable, after allowance for credit loss, current	1,214,098		1,214,098		1,116,273
Deferred billings	112,793		112,793		90,094
Allowance for credit losses, other assets	6,440		6,440		4,096
Net deferred billings	106,353		106,353		85,998
Allowance for credit losses current period charge	928	$ 267	5,344	$ 414
Factoring facility maximum capacity	60,000		60,000		75,000
Factoring facility, maximum capacity utilized	55,870		55,870		51,367
Factoring facility, amount outstanding	53,069		53,069		51,344
Cost of factoring facility	589	454	2,015	1,368
Accounts receivable, sale			191,295		$ 324,401
Cost of factoring facility with financial institution	$ 1,395	$ 2,011	$ 4,436	$ 5,981

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of fair value of assets and liabilities, including derivative instruments, at fair value on a recurring basis (Detail) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, assets	$ 15,324	$ 22,307
Deferred compensation plan assets	60,991	51,983
Total, assets	76,315	74,290
Derivative instruments, liabilities	35,067	17,363
Deferred compensation plan liability	60,354	51,354
Total, liabilities	95,421	68,717
Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, assets	0	0
Deferred compensation plan assets	0	0
Total, assets	0	0
Derivative instruments, liabilities	0	0
Deferred compensation plan liability	0	0
Total, liabilities	0	0
Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, assets	15,324	22,307
Deferred compensation plan assets	0	0
Total, assets	15,324	22,307
Derivative instruments, liabilities	35,067	17,363
Deferred compensation plan liability	0	0
Total, liabilities	35,067	17,363
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative instruments, assets	0	0
Deferred compensation plan assets	60,991	51,983
Total, assets	60,991	51,983
Derivative instruments, liabilities	0	0
Deferred compensation plan liability	60,354	51,354
Total, liabilities	$ 60,354	$ 51,354

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of roll-forward of fair value of earn-out consideration categorized as level 3 in fair value hierarchy (Detail) - Business acquisition contingent consideration - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 0	$ 0	$ 0	$ 2,517
Payments made on earn-out consideration	0	0	0	(2,399)
Change in fair value of earn-out consideration	0	0	0	(118)
Closing balance	$ 0	$ 0	$ 0	$ 0

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of roll-forward of fair value of deferred compensation plan assets categorized as level 3 in fair value hierarchy (Detail) - Deferred compensation assets - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 56,992	$ 47,975	$ 51,983	$ 40,261
Additions (net of redemption)	747	555	1,547	3,752
Change in fair value of deferred compensation plan assets	3,252	(1,586)	7,461	2,931
Closing balance	$ 60,991	$ 46,944	$ 60,991	$ 46,944

Fair Value Measurements - Roll-

Fair Value Measurements - Roll-forward of fair value of deferred compensation liabilities categorized as Level 3 in fair value hierarchy (Detail) - Deferred compensation liabilities - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 56,311	$ 47,313	$ 51,354	$ 39,654
Additions (net of redemption)	746	555	1,547	3,752
Change in fair value of deferred compensation plan liabilities	3,297	(1,536)	7,453	2,926
Closing balance	$ 60,354	$ 46,332	$ 60,354	$ 46,332

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	May 31, 2024	Dec. 31, 2023	Mar. 31, 2021
Interest rate swaps | Maximum
Derivative [Line Items]
Derivatives, maturity period	51 months
Forward foreign exchange contracts | Maximum
Derivative [Line Items]
Derivatives, maturity period	51 months
Treasury rate lock | 2021 Senior notes
Derivative [Line Items]
Treasury lock on fair value edges, amount				$ 350,000
Derivative instrument, gain amortized	$ 247		$ 368
Treasury rate lock | 2024 Senior notes
Derivative [Line Items]
Treasury lock on fair value edges, amount		$ 400,000
Derivative instrument, gain amortized	$ 371

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of aggregate notional principal amounts of outstanding derivative financial instruments with related balance sheet exposure (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Balance sheet exposure asset	$ (19,743)	$ 4,944
United States Dollars (sell) Indian Rupees (buy)
Derivative [Line Items]
Notional principal amounts	2,385,500	1,892,800
Balance sheet exposure asset	66	5,278
United States Dollars (sell) Mexican Peso (buy)
Derivative [Line Items]
Notional principal amounts	71,750	66,000
Balance sheet exposure asset	(6,907)	2,129
United States Dollars (sell) Philippines Peso (buy)
Derivative [Line Items]
Notional principal amounts	136,650	118,500
Balance sheet exposure asset	(4)	637
Euro (sell) United States Dollars (buy)
Derivative [Line Items]
Notional principal amounts	233,085	222,363
Balance sheet exposure asset	(3,822)	(3,499)
Euro (sell) Romanian Leu (buy)
Derivative [Line Items]
Notional principal amounts	16,740	66,384
Balance sheet exposure asset	296	90
Japanese Yen (sell) Chinese Renminbi (buy)
Derivative [Line Items]
Notional principal amounts	44,648	52,562
Balance sheet exposure asset	1,528	803
United States Dollars (sell) Chinese Renminbi (buy)
Derivative [Line Items]
Notional principal amounts	52,800	40,800
Balance sheet exposure asset	(369)	(638)
Pound Sterling (sell) United States Dollars (buy)
Derivative [Line Items]
Notional principal amounts	7,537	14,915
Balance sheet exposure asset	(495)	(398)
United States Dollars (sell) Hungarian Font (buy)
Derivative [Line Items]
Notional principal amounts	29,250	32,000
Balance sheet exposure asset	538	809
Australian Dollars (sell) Indian Rupees (buy)
Derivative [Line Items]
Notional principal amounts	123,127	90,077
Balance sheet exposure asset	(5,451)	(1,914)
United States Dollars (sell) Polish Zloty (buy)
Derivative [Line Items]
Notional principal amounts	47,250	51,000
Balance sheet exposure asset	2,165	3,046
Japanese Yen (sell) United States Dollars (buy)
Derivative [Line Items]
Notional principal amounts	7,000	7,000
Balance sheet exposure asset	121	323
Israeli Shekel (buy) United States Dollars (sell)
Derivative [Line Items]
Notional principal amounts	15,000	15,000
Balance sheet exposure asset	(53)	1,175
South African Rand (sell) United States Dollars (buy)
Derivative [Line Items]
Notional principal amounts	27,000	27,000
Balance sheet exposure asset	(3,087)	216
United States Dollars (sell) Brazilian Real (buy)
Derivative [Line Items]
Notional principal amounts	4,000	4,000
Balance sheet exposure asset	(29)	55
United States Dollars (sell) Costa Rica Colon (buy)
Derivative [Line Items]
Notional principal amounts	13,000	13,000
Balance sheet exposure asset	67	555
United States Dollars (sell) Canadian Dollar (buy)
Derivative [Line Items]
Notional principal amounts	9,000	0
Balance sheet exposure asset	(46)	0
Pound Sterling (buy) United States Dollar (sell)
Derivative [Line Items]
Notional principal amounts	0	22,300
Balance sheet exposure asset	0	669
United States Dollars (sell) Malaysian Ringgit (buy)
Derivative [Line Items]
Notional principal amounts	4,500	18,000
Balance sheet exposure asset	523	161
Interest rate swaps (floating to fixed)
Derivative [Line Items]
Notional principal amounts	237,500	148,125
Balance sheet exposure asset	$ (4,784)	$ (4,553)

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of fair value of derivative instruments and their location in the Company's financial statements (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Prepaid expenses and other current assets | Non-designated
Derivatives, Fair Value [Line Items]
Assets	$ 611	$ 5,783
Other assets | Non-designated
Derivatives, Fair Value [Line Items]
Assets	0	0
Accrued expenses and other current liabilities | Non-designated
Derivatives, Fair Value [Line Items]
Liabilities	4,896	1,276
Other liabilities | Non-designated
Derivatives, Fair Value [Line Items]
Liabilities	0	0
Cash flow hedges | Prepaid expenses and other current assets
Derivatives, Fair Value [Line Items]
Assets	10,156	13,273
Cash flow hedges | Other assets
Derivatives, Fair Value [Line Items]
Assets	4,557	3,251
Cash flow hedges | Accrued expenses and other current liabilities
Derivatives, Fair Value [Line Items]
Liabilities	11,311	6,833
Cash flow hedges | Other liabilities
Derivatives, Fair Value [Line Items]
Liabilities	$ 18,860	$ 9,254

Derivative Financial Instrume_6

Derivative Financial Instruments - Schedule gains (losses) recorded as component of other comprehensive income (loss) in connection with cash flow hedges (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Opening balance, before-tax amount	$ 11,651	$ 21,297	$ 805	$ (7,255)
Net gains (losses) reclassified into statement of income on completion of hedged transactions, before-tax amount	2,696	3,595	9,241	10,622
Changes in fair value of effective portion of outstanding derivatives, net, before tax amount	(24,537)	(9,872)	(7,146)	25,707
Gain (loss) on cash flow hedging derivatives, before tax amount	(27,233)	(13,467)	(16,387)	15,085
Closing balance, before-tax amount	(15,582)	7,830	(15,582)	7,830
Opening balance, tax (expense) or benefit	(3,927)	(5,368)	146	1,543
Net gains (losses) reclassified into statement of income on completion of hedged transactions, tax (expense) or benefit	(755)	(946)	(2,527)	(2,698)
Changes in fair value of effective portion of outstanding derivatives, net, tax (expense) or benefit	7,895	1,843	2,050	(6,820)
Gain (loss) on cash flow hedging derivatives, net, tax (expense) or benefit	8,650	2,789	4,577	(4,122)
Closing balance, tax (expense) or benefit	4,723	(2,579)	4,723	(2,579)
Opening balance, net of tax amount	7,724	15,928	951	(5,712)
Net gains (losses) reclassified into statement of income on completion of hedged transactions, net of tax amount	1,941	2,649	6,714	7,924
Changes in fair value of effective portion of outstanding derivatives, net, net of tax amount	(16,642)	(8,028)	(5,096)	18,887
Gain (loss) on cash flow hedging derivatives, net, net of tax amount	(18,583)	(10,677)	(11,810)	10,963
Closing balance, net of tax amount	$ (10,859)	$ 5,251	$ (10,859)	$ 5,251

Derivative Financial Instrume_7

Derivative Financial Instruments - Schedule of gains or losses recognized in other comprehensive income (loss) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other Comprehensive Income (Loss) [Line Items]
Changes in fair value of effective portion of outstanding derivatives, net	$ (24,537)	$ (9,872)	$ (7,146)	$ 25,707
Amount of gain (loss) reclassified from OCI into statement of income (effective portion)	2,696	3,595	9,241	10,622
Non designated hedges, amount of (gain) loss recognized in statement of income on derivatives	(3,473)	(5,689)	(3,908)	8,034
Revenue
Other Comprehensive Income (Loss) [Line Items]
Amount of gain (loss) reclassified from OCI into statement of income (effective portion)	414	(222)	1,326	1,007
Cost of revenue
Other Comprehensive Income (Loss) [Line Items]
Amount of gain (loss) reclassified from OCI into statement of income (effective portion)	1,569	2,199	5,617	1,301
Selling, general and administrative expenses
Other Comprehensive Income (Loss) [Line Items]
Amount of gain (loss) reclassified from OCI into statement of income (effective portion)	214	325	1,054	212
Interest expense
Other Comprehensive Income (Loss) [Line Items]
Amount of gain (loss) reclassified from OCI into statement of income (effective portion)	499	1,293	1,244	8,102
Forward foreign exchange contracts
Other Comprehensive Income (Loss) [Line Items]
Changes in fair value of effective portion of outstanding derivatives, net	(22,556)	(9,809)	(7,666)	24,076
Forward foreign exchange contracts | Foreign exchange gains (losses), net | Non-designated
Other Comprehensive Income (Loss) [Line Items]
Non designated hedges, amount of (gain) loss recognized in statement of income on derivatives	(3,473)	(5,689)	(3,908)	8,034
Interest rate swaps
Other Comprehensive Income (Loss) [Line Items]
Changes in fair value of effective portion of outstanding derivatives, net	(1,981)	(63)	917	1,631
Treasury rate lock
Other Comprehensive Income (Loss) [Line Items]
Changes in fair value of effective portion of outstanding derivatives, net	$ 0	$ 0	$ (397)	$ 0

Prepaid expenses and other cu_3

Prepaid expenses and other current assets - Schedule of prepaid expenses and other current assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Advance income and non-income taxes	$ 60,443	$ 90,136
Contract asset (Note 19)	19,433	17,454
Prepaid expenses	49,429	36,196
Derivative instruments (Note 5)	10,767	19,056
Employee advances	2,633	5,087
Deposits	5,446	4,406
Advances to suppliers	2,208	1,689
Others	13,705	17,542
Prepaid expenses and other current assets, net	$ 164,064	$ 191,566

Assets and liabilities held f_2

Assets and liabilities held for sale - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended			9 Months Ended		12 Months Ended
	Feb. 28, 2023	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2023	Nov. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on sale of business		$ 0		$ 0	$ 0	$ 802
The Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Percentage of issued and outstanding shares (in percent)								100%
Contingent consideration, asset								$ 10,600
Net consideration transferred	$ 2,091
Loss on sale of business	$ 802					$ (802)
Impairment charge on assets classified as held-for-sale							$ 32,575
The Business | Fixed Rate Unsecured Loan Note
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Interest rate on senior notes (in percentage)								1.50%
Debt instrument, face amount								$ 18,001
Revised redemption period									6 months
Reduced redemption value			$ 1,500						$ 1,500
Gain (loss) on extinguishment of debt			$ 1,500

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Schedule of gross and net amount of property, plant and equipment (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross	$ 820,082	$ 780,134
Less: Accumulated depreciation and amortization	(612,490)	(590,331)
Property, plant and equipment, net	$ 207,592	$ 189,803

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Narrative (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Property, Plant and Equipment [Line Items]
Depreciation and amortization			$ 51,830	$ 54,410
Depreciation on PPE
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 13,752	$ 12,198	40,937	37,466
Computer software
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 490	$ 664	$ 1,538	$ 2,060

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of changes in goodwill (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Opening balance	$ 1,683,782	$ 1,684,196
Effect of exchange rate fluctuations	(729)	(414)
Closing balance	$ 1,683,053	$ 1,683,782

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Changes in goodwill by reporting unit (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Opening balance	$ 1,683,782	$ 1,684,196
Effect of exchange rate fluctuations	(729)	(414)
Closing balance	1,683,053	1,683,782
Financial Services
Goodwill [Roll Forward]
Opening balance	408,674	408,736
Effect of exchange rate fluctuations	(120)	(62)
Closing balance	408,554	408,674
Consumer and Healthcare
Goodwill [Roll Forward]
Opening balance	592,780	592,907
Effect of exchange rate fluctuations	(229)	(127)
Closing balance	592,551	592,780
High Tech and Manufacturing
Goodwill [Roll Forward]
Opening balance	682,328	682,553
Effect of exchange rate fluctuations	(380)	(225)
Closing balance	$ 681,948	$ 682,328

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill deductible for tax purposes	$ 242,481		$ 242,481		$ 263,910
Amortization of acquired intangible assets	6,495	$ 7,497	19,980	$ 24,009
Property, plant and equipment
Goodwill And Intangible Assets Disclosure [Line Items]
Tangible asset impairment charges	0	0	0	0
Internally developed and other intangibles
Goodwill And Intangible Assets Disclosure [Line Items]
Amortization of acquired intangible assets	$ 534	$ 2,092	$ 1,490	$ 6,465

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of intangible assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Acquired Finite-Lived Intangible Assets [Line Items]
Gross  carrying amount	$ 703,469	$ 701,530
Accumulated amortization  & Impairment	670,132	648,502
Net	33,337	53,028
Customer-related intangible assets
Acquired Finite-Lived Intangible Assets [Line Items]
Gross  carrying amount	474,310	474,090
Accumulated amortization  & Impairment	451,902	436,104
Net	22,408	37,986
Marketing-related intangible assets
Acquired Finite-Lived Intangible Assets [Line Items]
Gross  carrying amount	97,855	97,840
Accumulated amortization  & Impairment	92,552	88,648
Net	5,303	9,192
Technology-related intangible assets
Acquired Finite-Lived Intangible Assets [Line Items]
Gross  carrying amount	131,304	129,600
Accumulated amortization  & Impairment	125,678	123,750
Net	$ 5,626	$ 5,850

Short-Term Borrowings - Narrati

Short-Term Borrowings - Narrative (Detail) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Aug. 31, 2018	Sep. 30, 2024	Dec. 31, 2023	Dec. 13, 2022
Line of Credit Facility [Line Items]
Fund-based and non-fund-based credit facilities limits available		$ 22,893,000	$ 23,302,000
Utilization of credit facility for non fund-based usage		$ 8,768,000	$ 9,336,000
Margin over LIBOR (in percentage)	1.375%
Commitment fee (in percentage)		0.20%	0.20%
Credit facility, amount utilized		$ 1,532,000	$ 11,627,000
Short-term borrowings		$ 0	$ 10,000,000
2022 facility | Base rate
Line of Credit Facility [Line Items]
Margin over LIBOR (in percentage)		1.375%
2022 facility | Base rate plus applicable margin
Line of Credit Facility [Line Items]
Debt instrument, basis spread on variable rate (in percentage)		0.375%
Minimum | 2022 facility
Line of Credit Facility [Line Items]
Term SOFR adjustment (in percentage)		0%	0%
Maximum | 2022 facility
Line of Credit Facility [Line Items]
Term SOFR adjustment (in percentage)		0.10%	0.10%
Revolving credit facility
Line of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity				$ 650,000,000
Non fund-based credit facility
Line of Credit Facility [Line Items]
Credit facility, amount utilized		$ 1,532,000	$ 1,627,000

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Detail) - USD ($)	1 Months Ended	9 Months Ended	12 Months Ended
	Aug. 31, 2018	Sep. 30, 2024	Dec. 31, 2023	Jun. 30, 2024	Mar. 31, 2021	Nov. 30, 2019
Debt Instrument [Line Items]
Margin over LIBOR (in percentage)	1.375%
Net debt to EBITDA leverage ratio, covenant line of credit		300%
Interest coverage minimum ratio, covenant line of credit		3
Long-term debt, amount		$ 1,627,508,000	$ 1,256,962,000
Term loan
Debt Instrument [Line Items]
Debt amortization expense		997,000	1,258,000
Long-term debt, amount		482,628,000	$ 508,867,000
Principal amount of term loan		$ 6,625,000
2022 facility | Minimum
Debt Instrument [Line Items]
Term SOFR adjustment (in percentage)		0%	0%
2022 facility | Maximum
Debt Instrument [Line Items]
Term SOFR adjustment (in percentage)		0.10%	0.10%
2022 facility | Line of credit
Debt Instrument [Line Items]
Debt instrument, face amount			$ 650,000,000
2022 facility | Term loan
Debt Instrument [Line Items]
Debt instrument, face amount			$ 530,000,000
Amended 2015 facility
Debt Instrument [Line Items]
Margin over LIBOR (in percentage)			0.20%
Credit facility, base rate (in percentage)			0.375%
2019 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount		$ 399,901,000	$ 399,464,000
2019 Senior notes | Genpact Luxembourg S.r.l.
Debt Instrument [Line Items]
Debt instrument, face amount						$ 400,000,000
Debt amortization expense		99,000	536,000
Long-term debt, amount		$ 399,901,000	399,464,000
Interest rate on senior notes (in percentage)		3.375%				3.375%
Total debt issuance cost						$ 2,937,000
Debt instrument redemption price (in percentage)		100%
Debt repurchase price as percentage of aggregate principal value upon certain change of controls (in percentage)		101%
Maximum increase in downgrade of credit rating of notes to adjust interest rate payable (in percentage)		2%
2021 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount		$ 349,082,000	348,631,000
2021 Senior notes | Genpact Luxembourg S.r.l.
Debt Instrument [Line Items]
Debt instrument, face amount					$ 350,000,000
Debt amortization expense		917,000	1,369,000
Long-term debt, amount		$ 349,083,000	348,631,000
Interest rate on senior notes (in percentage)		1.75%			1.75%
Total debt issuance cost					$ 3,032,000
Maximum increase in downgrade of credit rating of notes to adjust interest rate payable (in percentage)		2%
2024 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount		$ 395,897,000	$ 0
2024 Senior notes | Genpact Luxembourg S.r.l.
Debt Instrument [Line Items]
Interest rate on senior notes (in percentage)		6%
2024 Senior notes | Genpact Luxembourg and Genpact USA
Debt Instrument [Line Items]
Debt instrument, face amount				$ 400,000,000
Debt amortization expense		$ 4,103,000
Long-term debt, amount		$ 395,897,000
Interest rate on senior notes (in percentage)				6%
Total debt issuance cost				$ 4,395,000

Long-Term Debt - Schedule of ma

Long-Term Debt - Schedule of maturity profile of term loan outstanding net of debt amortization expense (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total	$ 1,627,508	$ 1,256,962
Term loan
Debt Instrument [Line Items]
2024	6,540
2025	26,173
2026	26,192
2027	423,723
Total	$ 482,628	$ 508,867

Long-Term Debt - Schedule of lo

Long-Term Debt - Schedule of long term debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023	Mar. 31, 2021	Nov. 30, 2019
Debt Instrument [Line Items]
Long-term debt, amount	$ 1,627,508	$ 1,256,962
Current portion	426,069	432,242
Non-current portion	1,201,439	824,720
Total	1,627,508	1,256,962
Term loan
Debt Instrument [Line Items]
Long-term debt, amount	482,628	508,867
Total	482,628	508,867
2019 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount	399,901	399,464
Total	399,901	399,464
2021 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount	349,082	348,631
Total	349,082	348,631
2024 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount	395,897	0
Total	395,897	0
Genpact Luxembourg S.r.l. | 2019 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount	399,901	399,464
Total	$ 399,901	399,464
Interest rate on senior notes (in percentage)	3.375%			3.375%
Genpact Luxembourg S.r.l. | 2021 Senior notes
Debt Instrument [Line Items]
Long-term debt, amount	$ 349,083	348,631
Total	$ 349,083	$ 348,631
Interest rate on senior notes (in percentage)	1.75%		1.75%
Genpact Luxembourg S.r.l. | 2024 Senior notes
Debt Instrument [Line Items]
Interest rate on senior notes (in percentage)	6%

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities - Schedule of accrued expenses and other current liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued expenses	$ 194,692	$ 165,378
Accrued employee cost	280,908	322,601
Statutory liabilities	65,306	76,022
Retirement benefits	1,806	2,386
Compensated absences	31,352	29,779
Derivative instruments (Note 5)	16,207	8,109
Contract liabilities (Note 19)	105,746	112,435
Finance leases liability	9,720	10,837
Other liabilities	41,752	31,633
Accrued expenses and other current liabilities, net	$ 747,489	$ 759,180
Finance lease, liability, current, statement of financial position [Extensible List]	Accrued expenses and other current liabilities, net	Accrued expenses and other current liabilities, net

Other Liabilities - Schedule of

Other Liabilities - Schedule of other liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Accrued expenses	$ 46,758	$ 40,866
Accrued employee cost	5,460	3,329
Retirement benefits	14,379	13,947
Compensated absences	51,362	50,214
Derivative instruments (Note 5)	18,860	9,254
Contract liabilities (Note 19)	54,277	59,393
Finance leases liability	8,834	6,874
Others	61,288	51,071
Other liabilities	$ 261,218	$ 234,948
Finance lease, liability, noncurrent, statement of financial position [extensible list]	Other liabilities	Other liabilities

Employee Benefit Plans - Schedu

Employee Benefit Plans - Schedule of net defined benefit plan costs (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Retirement Benefits [Abstract]
Service costs	$ 4,274	$ 3,781	$ 12,891	$ 11,290
Interest costs	1,994	1,750	6,028	5,221
Amortization of actuarial loss	60	166	182	500
Expected return on plan assets	(1,351)	(1,261)	(4,069)	(3,781)
Net defined benefit plan costs	$ 4,977	$ 4,436	$ 15,032	$ 13,230

Employee Benefit Plans - Sche_2

Employee Benefit Plans - Schedule of amounts contributed to defined contribution plans in various jurisdictions (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	$ 34,722	$ 33,278	$ 106,212	$ 100,324
India
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	14,029	12,369	40,517	35,407
U.S.
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	4,664	4,976	15,815	15,199
U.K.
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	4,227	4,295	14,246	14,457
China
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	7,315	6,787	21,625	20,309
Other Regions
Defined Contribution Plan Disclosure [Line Items]
Defined contribution plans, contributed amount	$ 4,487	$ 4,851	$ 14,009	$ 14,952

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Jul. 01, 2018	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Deferred compensation plan liability		$ 60,354		$ 60,354		$ 51,354
Cash surrender value of policies		60,991		60,991		$ 51,983
Change in fair value of plan assets		3,252	$ (1,586)	7,461	$ 2,931
Change in fair value of deferred compensation liabilities		$ 3,297	$ (1,536)	$ 7,453	$ 2,926
U.S.
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Vesting percentage of participants (in percentage)	100%
Employer discretionary vesting period	2 years
Earnings receivable minimum term	2 years
Earnings receivable lump sum or annual installment maximum terms	15 years
Deferred compensation arrangement with individual, maximum re-deferral contractual term	10 years
One-year anniversary of approval of contribution | U.S.
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Employer discretionary vesting percentage (in percentage)	50%
Two-year anniversary of approval of contribution | U.S.
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Employer discretionary vesting percentage (in percentage)	50%
Minimum | U.S.
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Individual qualifying base compensation (in percentage)	1%
Individual qualifying bonus compensation (in percentage)	1%
Maximum | U.S.
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Individual qualifying base compensation (in percentage)	80%
Individual qualifying bonus compensation (in percentage)	100%

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Detail) - USD ($) $ in Thousands				3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 05, 2022	Apr. 05, 2019	Apr. 11, 2012	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2012	May 09, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation cost				$ 19,516	$ 22,007	$ 46,381	$ 62,692
Options granted, contractual period, years						10 years
Unrecognized stock-based compensation cost for options				5,662		$ 5,662
Restricted stock unit vesting right (in shares)						1
Restricted stock unit vesting right, fair value (in shares)						1
Performance units vesting right (in shares)						1
Employee stock option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining requisite vesting period						1 year 8 months 12 days
Restricted share units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining requisite vesting period						1 year 10 months 24 days
Vested, number of shares (in shares)						385,515
Net settlement on vesting of restricted share unit (in shares)						256,393
Unrecognized stock-based compensation cost				52,495		$ 52,495
Restricted share units (RSUs) | Vesting period one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, number of shares (in shares)								9,103
Net settlement on vesting of restricted share unit (in shares)						4,983
Restricted share units (RSUs) | Vesting period two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, number of shares (in shares)									46,358
Net settlement on vesting of restricted share unit (in shares)						45,922
Performance units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average remaining requisite vesting period						2 years 1 month 6 days
Vested, number of shares (in shares)						1,362,776
Unrecognized stock-based compensation cost				$ 63,365		$ 63,365
Performance units | Prior to 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance units vesting right, fair value (in shares)						1
Performance units period						1 year
Performance units | 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance units period						3 years
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value per share allowed to eligible employees to purchase through payroll deductions (in percentage)						90%
Maximum percentage of employee's base salary allowed to be purchased (in percentage)				15%		15%
Maximum dollar amount of common shares allowed to be purchased						$ 25
Common shares reserved for issuance (in shares)				4,200,000		4,200,000
Issuance of common shares under the employee stock purchase plan (in shares)						261,281	255,123
Compensation expense for ESPP				$ 210	$ 307	$ 895	$ 1,158
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						3 years
Minimum | Restricted share units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						3 months
Minimum | Performance units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						5 years
Maximum | Restricted share units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						4 years
Maximum | Performance units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period						3 years
2007 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Amended omnibus plan, increase in number of common shares authorized for issuance (in shares)	3,500,000	8,000,000	5,593,200							8,858,823
Number of common shares authorized for issuance (in shares)	26,500,000	23,000,000	15,000,000
2017 Omnibus Incentive Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares authorized for issuance (in shares)											15,000,000

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of stock option activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Shares  arising out of options
Outstanding, shares arising out of options, beginning balance (in shares)	5,998,148
Granted, shares arising out of options (in shares)	0	0
Forfeited, shares arising out of options (in shares)	(226,691)
Expired, shares arising out of options (in shares)	(183,810)
Exercised, shares arising out of options (in shares)	(135,051)
Outstanding, shares arising out of options, ending balance (in shares)	5,452,596		5,998,148
Vested and expected to vest thereafter, shares arising out of options (in shares)	5,328,363
Vested and exercisable, shares arising out of options (in shares)	4,321,836
Weighted average grant-date fair value of options granted during the period (in usd per share)	$ 0
Weighted  average exercise price
Outstanding weighted average exercise price, beginning balance (in usd per share)	35.77
Granted, weighted average exercise price (in usd per share)	0
Forfeited, weighted average exercise price (in usd per share)	45.13
Expired, weighted average exercise price (in usd per share)	45.19
Exercised, weighted average exercise price (in usd per share)	29.11
Outstanding weighted average exercise price, ending balance (in usd per share)	35.23		$ 35.77
Vested and expected to vest thereafter, weighted average exercise price (in usd per share)	34.96
Vested and exercisable, weighted average exercise price (in usd per share)	$ 32.32
Weighted average remaining contractual life (years)
Outstanding weighted average remaining contractual life, beginning balance (years)	4 years 7 months 6 days		5 years 6 months
Vested and expected to vest thereafter, weighted average remaining contractual life (years)	4 years 7 months 6 days
Vested and exercisable, weighted average remaining contractual life (years)	4 years 1 month 6 days
Aggregate intrinsic value
Exercised, aggregate intrinsic value	$ 519
Outstanding as of September 30, 2024	34,216
Vested and expected to vest thereafter	34,216
Vested and exercisable as of September 30, 2024	$ 34,216

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of restricted share units activity (Detail) - Restricted share units (RSUs) - $ / shares	9 Months Ended
	Sep. 30, 2024
Number of Restricted Share Units
Outstanding number of shares (in shares), beginning balance	1,036,616
Granted (in shares)	1,788,839
Vested (in shares)	(385,515)
Forfeited (in shares)	(219,258)
Outstanding number of shares (in shares), ending balance	2,220,682
Expected to vest, number of shares (Units)	2,020,866
Weighted Average Grant Date Fair Value
Outstanding weighted average grant date fair value, beginning balance (in usd per share)	$ 42.87
Granted, weighted average grant date fair value (in usd per share)	34.13
Vested, weighted average grant date fair value (in usd per share)	41.75
Forfeited, weighted average grant date fair value (in usd per share)	39.58
Outstanding weighted average grant date fair value, ending balance (in usd per share)	$ 36.34
Net settlement on vesting of restricted share unit (in shares)	256,393

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of significant assumptions used in determining fair value of performance units (Detail) - Performance units	9 Months Ended
	Sep. 30, 2024
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	1.62%
Expected life (years)	2 years 4 months 17 days
Risk-free rate for expected life	3.83%
Volatility for expected life	24.24%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	1.81%
Expected life (years)	2 years 9 months 18 days
Risk-free rate for expected life	4.37%
Volatility for expected life	26.33%

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of performance units activity (Detail) - Performance units	9 Months Ended
	Sep. 30, 2024 $ / shares shares
Number of Performance Units
Outstanding number of shares (in shares), beginning balance	3,649,599
Granted, number of shares (in shares)	1,368,029
Vested, number of shares (in shares)	(1,362,776)
Forfeited, number of shares (in shares)	(356,375)
Outstanding number of shares (in shares), ending balance	3,298,477
Expected to vest, number of shares (Units)	3,352,715
Weighted Average Grant Date Fair Value
Outstanding weighted average grant date fair value, beginning balance (in usd per share) | $ / shares	$ 44.32
Granted, weighted average grant date fair value (in usd per share) | $ / shares	32.58
Vested, weighted average grant date fair value (in usd per share) | $ / shares	44.13
Forfeited, weighted average grant date fair value (in usd per share) | $ / shares	42.25
Outstanding weighted average grant date fair value, ending balance (in usd per share) | $ / shares	$ 39.75
Maximum Shares Eligible to Receive
Outstanding maximum shares eligible to receive, beginning balance (in shares)	4,977,057
Granted, maximum shares eligible to receive (in shares)	3,283,270
Vested, maximum shares eligible to receive (in shares)	(1,362,776)
Forfeited, maximum shares eligible to receive (in shares)	(618,831)
Outstanding maximum shares eligible to receive, ending balance (in shares)	6,278,720
Vested, net of withholding tax (in shares)	869,713

Capital Stock - Narrative (Deta

Capital Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended							9 Months Ended		12 Months Ended
	Feb. 08, 2024	Feb. 09, 2023	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Equity, Class of Treasury Stock [Line Items]
Stock repurchase authorized amount			$ 2,250,000							$ 2,250,000
Shares repurchased and retired (in shares)										4,720,308	3,828,084
Common stock shares repurchased price per share (in usd per share)										$ 35.50	$ 39.31
Expenses related to stock purchase										$ 294	$ 677
Stock repurchase program, remaining authorized repurchase amount			$ 231,983							$ 231,983
Increase in quarterly cash dividend (in percentage)	11%	10%
Dividend declared (in usd per share)			$ 0.1525		$ 0.1525	$ 0.1375		$ 0.1375	$ 0.125	$ 0.4575	$ 0.413		$ 0.55	$ 0.50
Dividends common stock			$ 26,939	$ 27,337	$ 27,492	$ 24,944	$ 25,031	$ 25,255		$ 81,768	$ 75,230
Forecast
Equity, Class of Treasury Stock [Line Items]
Dividend declared (in usd per share)												$ 0.61
O 2023 Q1 dividends
Equity, Class of Treasury Stock [Line Items]
Dividend declared (in usd per share)								$ 0.1375
O 2023 Q2 Dividends
Equity, Class of Treasury Stock [Line Items]
Dividend declared (in usd per share)							$ 0.1375
O 2024 Q2 Dividends
Equity, Class of Treasury Stock [Line Items]
Dividend declared (in usd per share)				$ 0.1525
Share repurchase open market
Equity, Class of Treasury Stock [Line Items]
Aggregate amount of common stock shares repurchased										$ 167,562	$ 150,471

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Number of stock awards outstanding but not included in the computation of diluted earnings per common share (in shares)	1,982,664	2,389,358	2,510,837	2,213,546

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share (Abstract)
Net income	$ 132,818	$ 117,593	$ 371,755	$ 339,946
Weighted average number of common shares used in computing basic earnings per common share (in shares)	177,595,400	181,399,897	179,221,213	182,808,518
Dilutive effect of stock-based awards (in shares)	2,118,823	2,401,894	1,633,469	2,929,211
Weighted average number of common shares used in computing diluted earnings per common share ( in shares)	179,714,223	183,801,791	180,854,682	185,737,729
Earnings per common share, basic (in usd per share)	$ 0.75	$ 0.65	$ 2.07	$ 1.86
Earnings per common share, diluted (in usd per share)	$ 0.74	$ 0.64	$ 2.06	$ 1.83

Segment Reporting - Narrative (

Segment Reporting - Narrative (Detail)	9 Months Ended
	Sep. 30, 2024 numberOfOperatingSegment
Segment Reporting [Abstract]
Number of reportable segments	3

Segment Reporting - Revenues an

Segment Reporting - Revenues and adjusted income from operations by reportable segments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net revenues	$ 1,210,949	$ 1,135,792	$ 3,518,398	$ 3,330,635
AOI	212,961	194,994	593,254	559,946
Total excluding business held for sale				3,330,145
Stock-based compensation	(19,726)	(22,314)	(47,276)	(63,850)
Amortization and impairment of acquired intangible assets (other than included above)	(6,494)	(7,495)	(19,963)	(23,895)
Foreign exchange gains, net	1,133	2,975	4,424	3,698
Interest income (expense), net	(12,387)	(13,255)	(36,167)	(35,020)
Restructuring (expense) / income				4,874
Loss on the sale of the business classified as held for sale (refer to Note 7)	0	0	0	(802)
Income tax expense	(42,669)	(37,312)	(122,517)	(103,804)
Net income	132,818	117,593	371,755	339,946
Disposal group, held-for-sale, not discontinued operations
Segment Reporting Information [Line Items]
Revenue from operations held for sale				(490)
Charges from operations held for sale			1,921	(1,201)
Charges from operations held for sale			(1,921)	1,201
Data-Tech-AI
Segment Reporting Information [Line Items]
Net revenues	569,420	523,370	1,639,298	1,558,279
Digital operations
Segment Reporting Information [Line Items]
Net revenues	641,529	612,422	1,879,100	1,772,356
Operating Segments
Segment Reporting Information [Line Items]
Net revenues	1,210,949	1,135,792	3,518,398	3,330,635
Operating Segments | Financial Services
Segment Reporting Information [Line Items]
Net revenues	331,552	313,487	957,164	913,410
AOI	58,271	52,991	158,369	145,291
Operating Segments | Consumer and Healthcare
Segment Reporting Information [Line Items]
Net revenues	426,065	393,919	1,253,441	1,174,433
AOI	74,465	62,299	211,987	177,581
Operating Segments | High Tech and Manufacturing
Segment Reporting Information [Line Items]
Net revenues	453,332	428,386	1,307,793	1,242,792
AOI	81,180	83,102	224,819	217,014
Operating Segments | Data-Tech-AI
Segment Reporting Information [Line Items]
Net revenues	569,420	523,370	1,639,298	1,558,279
Operating Segments | Data-Tech-AI | Financial Services
Segment Reporting Information [Line Items]
Net revenues	158,579	138,194	450,813	418,219
Operating Segments | Data-Tech-AI | Consumer and Healthcare
Segment Reporting Information [Line Items]
Net revenues	197,438	180,190	576,450	549,760
Operating Segments | Data-Tech-AI | High Tech and Manufacturing
Segment Reporting Information [Line Items]
Net revenues	213,403	204,986	612,035	590,300
Operating Segments | Digital operations
Segment Reporting Information [Line Items]
Net revenues	641,529	612,422	1,879,100	1,772,356
Operating Segments | Digital operations | Financial Services
Segment Reporting Information [Line Items]
Net revenues	172,973	175,293	506,351	495,191
Operating Segments | Digital operations | Consumer and Healthcare
Segment Reporting Information [Line Items]
Net revenues	228,627	213,729	676,991	624,673
Operating Segments | Digital operations | High Tech and Manufacturing
Segment Reporting Information [Line Items]
Net revenues	239,929	223,400	695,758	652,492
Others
Segment Reporting Information [Line Items]
AOI	$ (955)	$ (3,398)	$ (1,921)	$ 18,859

Net Revenues - Schedule of net

Net Revenues - Schedule of net revenues disaggregated by customer (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Reporting Information [Line Items]
Net revenues	$ 1,210,949	$ 1,135,792	$ 3,518,398	$ 3,330,635
Data-Tech-AI
Segment Reporting Information [Line Items]
Net revenues	569,420	523,370	1,639,298	1,558,279
Digital operations
Segment Reporting Information [Line Items]
Net revenues	$ 641,529	$ 612,422	$ 1,879,100	$ 1,772,356

Net Revenues - Narrative (Detai

Net Revenues - Narrative (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) numberOfOperatingSegment	Sep. 30, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Number of reportable segments | numberOfOperatingSegment			3
Revenue recognized in contract liabilities balance | $	$ 53,189	$ 55,007	$ 98,750	$ 140,379
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2024-01-10
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	6 months		6 months
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2025-01-01
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	2 years		2 years
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2027-01-01
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	2 years		2 years
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2029-01-01
Disaggregation of Revenue [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period

Net Revenues - Schedule of deta

Net Revenues - Schedule of details of contract balances (Detail) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Revenues [Abstract]
Contract assets	$ 36,285	$ 33,370
Deferred transition revenue
Contract Liabilities [Line Items]
Contract liabilities	112,504	116,577
Advance from customers
Contract Liabilities [Line Items]
Contract liabilities	$ 47,519	$ 55,251

Net Revenues - Schedule of esti

Net Revenues - Schedule of estimated revenue expected to be recognized in the future related to remaining performance obligation (Detail) $ in Thousands	Sep. 30, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Transaction price allocated to remaining performance obligations	$ 160,023
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2024-01-10
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Transaction price allocated to remaining performance obligations	105,746
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Transaction price allocated to remaining performance obligations	42,193
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Transaction price allocated to remaining performance obligations	9,796
Revenue, remaining performance obligation, expected timing of satisfaction, start date [Axis]: 2029-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Transaction price allocated to remaining performance obligations	$ 2,288

Net Revenues - Schedule of cont

Net Revenues - Schedule of contract cost assets (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Opening balance			$ 202,543
Closing balance	$ 200,440		200,440
Sales incentive programs
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Opening balance	40,252	$ 37,556	41,964	$ 34,805
Closing balance	40,078	38,411	40,078	38,411
Amortization	7,604	7,446	21,286	22,012
Transition activities
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Opening balance	163,150	156,231	160,579	181,865
Closing balance	160,362	158,718	160,362	158,718
Amortization	$ 20,060	$ 20,354	$ 57,075	$ 68,460

Other operating (income) expe_3

Other operating (income) expense, net - Schedule of other operating (income) expense, net (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Other Income and Expenses [Abstract]
Loss on the sale of business classified as held for sale (refer to Note 7)	$ 0	$ 0	$ 0	$ 802
Gain on termination of lease (refer to Note 24)				(4,874)
Other operating (income) expense*	(22)	(91)	(5,561)	(593)
Other operating (income) expense, net	$ (22)	$ (91)	$ (5,561)	$ (4,665)

Interest Income (Expense), Ne_2

Interest Income (Expense), Net - Schedule of interest income (expense), net (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Banking and Thrift, Interest [Abstract]
Interest income	$ 10,323	$ 4,582	$ 22,718	$ 13,005
Interest expense	(22,710)	(17,837)	(58,885)	(48,025)
Interest income (expense), net	$ (12,387)	$ (13,255)	$ (36,167)	$ (35,020)

Income taxes - Narrative (Detai

Income taxes - Narrative (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate (in percentage)	24.30%	24.10%	24.80%	23.40%
Unrecognized tax benefits that would impact effective tax rate	$ 18,771		$ 18,771		$ 19,236
Unrecognized tax benefits, interest on income taxes accrued	3,387		3,387		3,312
Accrued penalties	$ 512		512		499
Unrecognized tax benefits, excluding exchange rate differences for interest recognized			$ (813)		$ 220

Income taxes - Schedule of acti

Income taxes - Schedule of activities related to unrecognized tax benefits for uncertain tax positions (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Opening balance at January 1	$ 19,236
Decrease related to prior year tax positions due to lapse of applicable statute of limitation	(37)
Decrease related to settlements with taxing authorities	(341)
Effect of exchange rate changes	(87)
Closing balance at September 30	$ 18,771

Commitments and contingencies (

Commitments and contingencies (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Commitments And Contingencies [Line Items]
Bank guarantees and letters of credits, outstanding	$ 10,300	$ 10,963
Unrecognized tax benefits	18,771	19,236
Ministry of Finance, India
Commitments And Contingencies [Line Items]
Loss contingency, estimate of possible loss	110,448
Unrecognized tax benefits	0
Capital addition purchase commitments
Commitments And Contingencies [Line Items]
Commitments and contingencies	$ 33,533	$ 15,982

Restructuring (Detail)

Restructuring (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring income				$ 4,874
Office premises and employee severance charge
Restructuring Cost and Reserve [Line Items]
Restructuring income	$ 0	$ 0	$ 0	$ 4,874

Subsequent events (Detail)

Subsequent events (Detail) - $ / shares		3 Months Ended					9 Months Ended		12 Months Ended
	Oct. 17, 2024	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Dividends per common share (in usd per share)		$ 0.1525	$ 0.1525	$ 0.1375	$ 0.1375	$ 0.125	$ 0.4575	$ 0.413	$ 0.55	$ 0.50
Subsequent Event
Subsequent Event [Line Items]
Dividends per common share (in usd per share)	$ 0.1525